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Abstract
Studies have found a link between cardiovascular risk factors (CVRFs) and Alzheimer’s
disease however; the mechanism by which CVRFs increase the risk of cognitive decline is
not fully understood. The current study attempts to improve CVRFs in order to enhance
cognition in older adults. Primary outcomes include ambulatory and clinical resting systolic
and diastolic blood pressure (SBP; DBP). In total, 89 community-dwelling older adults with
subjective cognitive complaints were randomized to either a multiple-modality mind-motor
(M4) exercise or a multiple-modality (M2) exercise only. Significance was found in
nighttime peak SBP (6.55 mmHg, p=.04) between groups, with a decrease in M2 compared
to M4. Clinical resting SBP also decreased (6.99 mmHg, p=.03) between groups, whereby
M4 further decreased compared to M2. Both M2 and M4 have some influence on ambulatory
and clinical resting BP however, further research is required to elicit the effects of M4 and
M2 on CVRFs.
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Chapter 1 : Introduction
Brief Introduction to Thesis
Cognition is referred to as the mental act or process by which knowledge is developed
through the incorporation of perception, intuition, reasoning and judgement. According to
Hendrie et al., cognitive health, much like physical health (i.e. vascular health), can be
viewed along a continuum; ranging from optimal functioning to mild cognitive
impairment to severe dementia such as Alzheimer’s disease1. As the population continues
to age, the prevalence of age-related diseases such as Cardiovascular Disease (CVD) and
dementia are increasing2. There is growing support associated with the significance of
cardiovascular risk factors (CVRFs) and the advancement of dementia, including
Alzheimer’s disease (AD)2.

Increased blood pressure, along with the associated stiffening of arteries are some CVRFs
that reduce cerebrovascular vasoreactivity and cerebral blood flow and render older
adults to a greater risk of decreased blood flow in the brain3,4, and poorer cognitive
function. Sustained hypertension is also coupled with the formation of white matter
lesions5,6, hippocampal atrophy7, the occurrence of neurotropic markers of AD8 and
clinical dementia8,9. Furthermore, age and sex also impact CV health. The Framingham
Heart Study, a longitudinal study which followed participants for 40 years found a
continuous increase in systolic blood pressure (SBP) between the ages of 30 and 84
years. Diastolic blood pressure (DBP) has greater variability in ageing with an increase
up to the late 50’s and then a decrease from the age 60 to 84 years of age. This variance
in BP creates a steep incline in pulse pressure with ageing10,11. Sex, specifically females
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have a greater susceptibility to CVD in ageing12. Ford et al., explained the longer life
expectancy within females comprises a greater fraction of the older adult population
where CVD is most prevalent12. Therefore, both age and sex may influence CV health
and lifestyle modifications should be done in order to control the risk of CVD and its
associated risk factors.
Aerobic exercise (AE) has shown to overturn elevated central arterial stiffness in healthy
middle-aged and older subjects9 by enhancing blood flow in the brain’s pre-frontal cortex,
while resistance training can augment hippocampal volume and circulating neural growth
factors, which are all proposed mechanisms that protect or improve cognition as we
age13. For instance, a review by Lange-Asschenfeldt & Kojda concluded that exercise
training reduces vascular oxidative stress and improves vascular endothelial function,
both of which promote greater arterial compliance and cerebral blood flow14. Since
decreased arterial compliance has been related to increased cerebrovascular resistance15,
and reduced cerebrovascular resistance has been observed during antihypertensive
therapy16, the use of AE to reverse hypertension (i.e., reduced arterial stiffness) may be a
method to improve cognition in at-risk patients for cognitive decline who have CVD.
Observational studies have revealed physical activity as a primary method to improve
vascular health, cognitive function and delay or prevent the onset of dementia17-21. It has
also been suggested that a multiple modality (M2), (combined AE, resistance and
stretching exercises) have optimal effect on cognition when compared to providing each
type independent of one another22-24. In addition, cognitive training (CT) has also shown
improved cognition, which is gaining more attention. Observational studies have found
2

CT to be just as effective at improving cognition as administering AE for older adults at
risk of cognitive decline25. The exploration of a collective physical and cognitive exercise
program is critical for the advancement of understanding by which different domains of
exercise can impart cognitive benefits in aging25.
There are very few randomized controlled trials that have investigated the effects of
modifying vascular risk factors on cognitive health and functioning in either healthy older
adults, or those with a cognitive complaint, mild cognitive impairment (MCI), or
dementia13 through the incorporation of CT. Therefore, a systematic review was
conducted to establish the state of the literature available regarding the effects of CT with
or without exercise on cardiovascular (CV) health in older adults and to see whether a
specific program of CT and/or exercise warrants prescription for older adults at risk for
future cognitive decline26 through the improvement of CVRFs.
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Chapter 2: Systematic Review
The effect of cognitive training (CT) on cardiovascular health in
community-dwelling older adults: A systematic review
Amanda M Deosaran1,2, Sanjit K Bhogal4 PhD, Dawn P Gill2,3,4,7 PhD, Michael
Gregory2,6, Robert J Petrella1,2,6,7 MD, PhD
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School of Kinesiology, Faculty of Health Sciences, Western University, London, Ontario, Canada;
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Lawson Health Research Institute, London, Ontario, Canada; 3School of Health Studies, Western

University, London, Ontario, Canada; 4Department of Epidemiology, University of Washington, Seattle,
Washington, United States; 5Department of Surgery, St. Michael’s Hospital, Toronto, Ontario, Canada;
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Department of Health & Rehabilitation Sciences, Faculty of Health Sciences, University of Western

Ontario, Canada; 7Department of Family Medicine, Schulich School of Medicine and Dentistry, Western
University , London, Ontario, Canada

KEY WORDS: cognitive training, vascular risk factors, aging, community-dwelling
adults, systematic review
BACKGROUND: Exercise training may mitigate the impact of vascular risk factors on
cognitive function in older adults; however, whether cognitive training can modify
vascular risk factors is unclear.
OBJECTIVE: To systematically review the impact of cognitive training on vascular
health in community-dwelling older adults.
Data Sources: A systematic review of English articles from year 2000 and onwards using
CINAHL, Pub Med, PsycINFO, Scopus, EMBASE databases.
STUDY SELECTION: Only clinical trials (RCTs or nonrandomized studies) that
assessed the effects of CT, administered with or without an exercise or physical activity
component. Studies were eligible for inclusion if they studied the effectiveness of CT
among healthy or cognitively impaired community-dwelling older adults aged 55 years or
older.
DATA EXTRACTION: One author independently selected the trials, and two authors
assessed trial quality and extracted necessary data.
OUTCOMES: The primary outcome of interest was: systolic blood pressure. Secondary
4

outcomes included: diastolic blood pressure, lipids, inflammatory markers (i.e. Brain
derived neurotrophic factor, BDNF; Insulin-like growth factor 1, IGF-1), vascular
mechanics (i.e. arterial stiffness, intima-media thickness, dispensability), heart rate
variability and maximum oxygen uptake (Vo2max)] or any other vascular risk factors
associated with dementia (i.e. cerebral blood flow).
RESULTS: Four articles were included for qualitative synthesis. Each study reported on
at least one vascular outcome. One study showed a significant increase in regional
cerebral blood flow (43.6 to 59.2 ml/100·g tissue/min) and another article demonstrated a
significant improvement in clinical systolic (140.06 to 128.97 mmHg) and diastolic
(76.41 to 73.41 mmHg) blood pressure. However, the remaining two articles that looked
at VO2max, revealed controversial results.
CONCLUSIONS Although limited studies have shown noteworthy improvement
following CT in some areas of vascular health (i.e. cerebral blood flow, blood pressure
and VO2max), more research is needed to confirm and include a greater number of
outcomes in cardiovascular health.
Corresponding Author
Robert J Petrella, MD, PhD
Western Centre for Public Health and Family Medicine (PHFM)
1465 Richmond Street, 2nd Floor
Western University
London, ON, N2G 2M1
petrella@uwo.ca

INTRODUCTION
The incidence of age-related diseases such as cardiovascular disease (CVD) and dementia
are expected to significantly increase as the population ages27. Canada's aging
population, combined with alarming trends in cardiovascular risk factors (CVRFs) such
as obesity, physical inactivity, hypertension, and diabetes are expected to further increase
the risk of dementia including Alzheimer’s disease (AD)27-29.
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The World Health Organization (WHO) has estimated by 2030, more than 23 million
people will die annually from CVD30. In 2008, nearly 14 million deaths occurred after the
age of 60 and more than 3 million deaths occurred before the age of 6030. The WHO has
also projected that the total number of people with dementia will almost double every 20
years to 65.7 million in 2030 and 115.4 million by 205031. Despite the increasing
prevalence of dementia in the older adult population, there is currently no effective
treatment. Hence, some studies have investigated targeting modifiable CVRFs to
mitigate cognitive decline31.
The brain depends on a continuous supply of regulated blood flow, therefore, cognitive
health and function is partially reliant upon cardiovascular (CV) dynamics32. Many
studies have focussed on the effect of blood pressure, specifically systolic blood pressure
(SBP) and its influence on cognition33-35. Cross-sectional research studies have found an
association between hypertension (SBP >140 mm Hg; DBP > 90 mm Hg) and cognitive
decline in adults aged 55 years or more in various ethnicities33-35. Similarly, longitudinal
studies observed comparable results, whereby adults aged 60 years and older who were
hypertensive or had continually high SBP in midlife, had a higher risk of AD occurrence
in late life or suffered from significant cognitive decline36,37. See Table 1 for blood
pressure (BP) studies on cognition.
Furthermore, other CVRFs including inflammatory marker variability, decreased total
serum cholesterol, lowered high density lipoprotein (HDL), reduced heart rate variability
(HRV) and increased arterial stiffness were all associated with cognitive decline38-40. See
Table 2 for other CVRFs studies on cognition
6

Table 1: BP Studies on Cognition
Cross sectional BP Studies

Author

Study Population

CVRF

Main Results

Kuo et al.33

aged ≥65 years old,

SBP

SBP >145 mm Hg linked to impaired

healthy
Steward et
al.

34

British African, 55-75

executive function
BP

Clinically diagnosed hypertension and

years old

Andre-

Swedish Men, aged

Petersson et

68+ years old

cognitive impairment are linked
BP ≥180/110 mm Hg was related to

BP

poorer performance on the

al.35

neuropsychological test battery

Longitudinal BP studies
Wu et al.36

Chinese, ≥65 years

21 year

Hypertension (160/95 mm Hg) in

old

follow-up

midlife was related to a higher risk of

BP

AD prevalence in late-life11

Waldstein et

Baltimore, 60-96

11 year

SBP (continuous variable) was

al.37

years old

follow-up

associated with decreased cognitive

SBP

performance, and greater cognitive
decline when asked to complete a
series of neuropsychological tests12.

Abbreviations: BP, blood pressure; SBP, systolic blood pressure; AD, Alzheimer’s Disease;
mm Hg, millimeters of mercury
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Table 2: Other CVRFs Studies on Cognition
Other CVRFs studies
Author

Study Population

CVRF

Main Result(s)

Metti et al.38

Non-demented,

Inflammatory

CRP variability reflected poor

70-79 years old

marker: C-

control of, or more, pronounced

reactive protein

changes in vascular or metabolic

(CRP) over 10

disease over time leading to an

years

associative cognitive decline

Non-demented,

Total serum

Lower total serum cholesterol and

elderly

cholesterol,

lower high density lipoprotein

high density

(HDL) were connected with

lipoprotein

reduced cognitive ability

Kim et al.39 and
Atzmon et al.

40

(HDL)
Al Hazzouri and
Yaffe

41

Mexican-

Heart rate

Found an association between

American,

variability

reduced HRV and poorer cognitive

community-

(HRV)

function

Arterial

Increase in arterial stiffness was

stiffness

coupled with lower cognitive

dwelling older
adults
Al Hazzouri and
Yaffe42

Older adults

performance. This was observed on
measures of global cognition and
over several domains of cognition

Other study interventions have improved CVRFs, which subsequently slowed cognitive
decline. Burns et al. conducted a study of brain atrophy and cardiorespiratory fitness,
specifically VO2peaks (the highest value of volume of oxygen attained during a
particular fitness test) in subjects without dementia and subjects with early onset of AD.
8

They found an increase in VO2peaks were associated with a decrease in brain atrophy in
non-demented elderly subjects43.
The Rotterdam study also observed a higher cerebral blood flow (CBF) velocity and its
association with a lower likelihood of getting dementia44. Lastly, Fukuhara and
colleagues suggested that arterial stiffness could predict cognitive function in the elderly,
specifically pulse wave velocity (PWV), which was independently associated with MiniMental State Examination (MMSE) scores45. Increasing evidence suggests the
contribution of CVRFs to cognitive health and therefore, it is imperative to find ways to
mediate such risk factors due to their significant role in cognition32.
Studies that utilized exercise interventions have found beneficial effects on CV health46.
Exercise is described as a method of physical activity that is a structured routine extended
over a period of time with intentions of enhancing fitness, function or health47. Exercise
training can be administered in various forms such as dynamic/isometric resistance or
strength training which improve muscle mass; aerobic exercise (AE) training whereby it
decreases arterial stiffness; flexibility and balance training which aid in posture; and
mobility training which decreases the risk of falls46. Many studies have used exercise,
specifically AE to improve CV health in older adults. One study found AE preserved
endothelial function with aging and directly induced arterial protection. Seals and Adolph
concluded that AE should be used as a “first line” strategy for prevention and treatment
of arterial health48. Furthermore, a study by Ten Brinke et al., observed after six months
of AE training, a significant enhancement in hippocampal volume in older women with
possible mild cognitive impairment (MCI)49. Although studies have looked at exercise to
9

improve CV health, it is still uncertain whether exercise in its entirety, is the most
beneficial method for improving CV health.
Cognitive training (CT) has been considered another form of exercise, specific for the
brain, which acts as a protective factor as we age and may be a possible prevention
measure for cognitive impairment50. For the objective of this systematic review, CT are
defined as “structured, repetitive practices on tasks with a distinctive problem, using
standardized tasks targeting specific cognitive domains and/or teaching strategies and
skills in order to optimize cognition and functioning”51,52. Cognitive training
interventions incorporate training of executive function networks of the brain to segregate
attention and co-ordinate actions more efficiently and effectively53. Research suggests
that executive control processes and their underlying brain regions are plastic and can be
modified by CT54. Examples of CT include non-computer based training programs such
as a study done by Oshugi et al., who compared a single task (either doing calculations or
performing step climbing) and dual task (performing both single tasks simultaneously)55.
Another study used a novel square stepping exercise, whereby participants had to
remember a demonstration of a stepping pattern and then perform it on a mat partitioned
by squares56. Computer based CT are also used, such as variable priority training
developed by Kramer et al.57, and examined by MacKay-Brandt58. This task involves
performing two concurrent tasks on a computer. For example, one version of this task
required “cutting” a flower image at random locations on the monitor (cutting requires
the participant to use the mouse to position an image of scissors over the flower and
clicking). Instantaneously, single digits bounded in a box were shown serially in the
middle of the monitor whereby participants had to press a number key to indicate the
10

correct sum. Other CT have involved music or a musical instrument59, choreographed
dance60 or various dual-tasks such as walking on a treadmill while completing another
task23.
Furthermore, studies have also compared CT and AE to examine which method was more
beneficial. Klusman and colleagues recognized objective measures of memory and
executive function (EF) (Trail Making Test B divided by A) were preserved or enhanced
in older women with mild cognitive impairment (MCI; MMSE ≥ 20) after receiving 6
months of either CT or AE. Interestingly, cognitive function improved to a similar extent
in both individuals receiving CT or AE61. This suggests CT may be a possible
intervention to reduce the risk of cognitive decline analogous to AE in older adults with
MCI, and that CT may pass on similar effects to individuals who are free of MCI.
It is uncertain whether cognitive training will instil similar effects on CV health despite
the interrelation between cognitive function and CV health. The exploration of CT with
or without an exercise program on vascular health is still critical for the advancement of
understanding by which CT, as a type of exercise, can affect CV health in aging. This
systematic review aims to: 1) examine the effects of CT, with and without exercise, on
SBP in community-dwelling older adults with and without cognitive impairment but no
dementia, and 2) identify whether any other CVRFs are improved by CT.
The research question for this systematic review was developed using the PICO:
Population, Intervention, Comparison and Outcome(s)
(http://learntech.physiol.ox.ac.uk/cochrane_tutorial/), framework. Xiaoili and colleagues
investigated the validity and suitability of the PICO framework and confirmed its
appropriateness for structuring clinical questions62. Our review question is stated as:
11

Among community-dwelling adults (aged 55 years and older) with and without cognitive
impairment, do those who receive CT alone or in combination with any form of exercise
have improved vascular health [such as lower blood pressure (systolic and diastolic),
higher maximum oxygen uptake (Vo2max), or improved lipids, inflammatory markers
(i.e., BDNP, IGF-1)], vascular mechanics (i.e., arterial stiffness, intima-media thickness
(IMT), dispensability), and heart rate variability, compared to those who received an
alternative therapy.
METHODS
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines and statement were used as a protocol for this review63. Registration of this
systematic review was completed through Prospero, an international prospective register
for systematic reviews (registration #CRD42014013876).
Eligibility
Types of Studies
Eligibility for inclusion consisted of trials, irrespective of randomization, which evaluated
CT against an appropriate comparator intervention that did not include a CT intervention.
Studies used either a randomized controlled trial (RCT) or nonrandomized intervention
trial. The article had to address any confounding factors (i.e. race/ethnicity/culture,
gender, education, age, CVRFs) and compare study participants to at least one of the
possible confounding factors.
Types of Participants
Community-dwelling adult population, aged 55 years or older were considered.
12

Participants were excluded if they (1) self-reported (based on diagnosis by a physician) or
suspected to have dementia based on study specific assessments [(i.e. neurological
examination such as the Mini-mental State Examination (MMSE), Montreal Cognitive
Assessment (MoCA ) or other assessment tools], (2) presented with other neurological or
psychiatric conditions, including, Parkinson’s Disease; Bipolar disease, Schizophrenia,
ADHD, Bipolar disorder, cerebral palsy, Horton disease, Downs Syndrome, Epilepsy,
Fibromyalgia, Huntington’s disease, Intracranial Hypertension, Neurofibromatosis, TaySachs disease, Tourette Syndrome, Traumatic brain injury, or (3) who have not
experienced a major cardiovascular event in last 2 years, were included.

Types of Intervention
The intervention of interest was CT. Both computer- and non-computer-based CT
interventions were considered. The CT intervention could occur in isolation or in
combination with exercise. The following exercise components were accepted: (1)
Aerobic exercises (water-based exercises, yard work, dancing, biking, climbing stairs,
field sports, basketball, tennis, hockey, football, aerobics); (2) Strength exercises (weight
lifting, resistance training, muscle training); (3) Balance exercises (martial arts, tai-chi,
qigong); (4) Flexibility exercises (yoga, upper and lower body stretches); and (5) Other
type of exercise deemed appropriate by the study authors (i.e. Wii-based exercise
program60, coordination training64, functional tasks exercises65). Cognitive training
interventions that also included diet or pharmacological components were excluded. The
comparator group had to be an alternative therapy that excluded CT, such as standard or
usual care, active control (non-CT group), or allocated to a wait-list group.
13

Outcome
Main Outcome
The primary outcome of interest was ambulatory SBP (measured in mm Hg).
Ambulatory blood pressure gives a valuable sense of how one’s blood pressure fluctuates
in regular activities performed throughout the day. Blood Pressure patterns over 24 hours
could also have inferences about cognitive function, however not many studies have
focussed on ambulatory BP58. The US Preventative Services Task Force is also
considering having an ambulatory blood pressure monitor (ABPM) as an inclusion factor
for the screening and diagnosis of hypertension66. Therefore, if ABPM’s become widely
accepted, comprehending its interaction in addition to age-related outcomes such as
cognitive function will be beneficial for the population at large67.
Secondary Outcomes
Other CV outcomes that were considered included: (1) ambulatory DBP, (2) carotid
arterial stiffness, (3) other arterial stiffness (not carotid), (4) carotid intima-media
thickness, (5) intima-media thickness (not carotid), (6) distensibility, (7) VO2max, (8)
heart rate variability, (9) lipids (i.e. triglycerides, steroids, phospholipids), (10)
inflammatory markers [(i.e. BDNP, endothelial markers, adhesion molecules, IGF-1,
cytokines (i.e. IL-1, IL-6, TNF-α), acute-phase reactants (i.e. fibrinogen, SAA, CRP),
white blood cell count)], and (11) other CV outcomes (i.e. cerebral blood flow, pulse
pressure, pulse wave velocity).
Sociodemographic Factors
The following sociodemographic factors were considered for influences associated with
14

CV health. Place of residence was categorized by geographical location, and classified by
urban or rural. Race was defined by the following categories: Caucasian, African
American, Asian, or other. Sex was categorized by male or female. Level of education
was defined as: primary education, secondary education, post-secondary (non-trade),
post-secondary (trades), graduate or other. Age was documented by mean, mean
interquartile range and/or by categories: 55-64, 65-74, 75-84 and 85+ years.
Information Sources
Studies were identified by searching electronic databases, reviewing reference lists of
eligible articles and consulting with experts in the field. The search strategy was
developed with the help of experts in the field and aid of an experienced librarian from
the Taylor Library, Western University. Restrictions were implemented for English
language only and published in 2000 onwards. A limit on date was set due to the rarity of
research in CT prior to 2000. The following databases were searched: Pubmed,
CINAHL, EMBASE, Scopus, PsycINFO. We also searched secondary sources,
including, the Cochrane library, Prospero database, and Google Scholar. Furthermore, we
manually searched the reference lists of all included articles and contacted one author to
acquire a full text version of their study. The final search was completed in July 2014
with an updated search performed at the beginning of January 2015.
Search Strategy
The following terms were used in the search strategy (note: each term was searched
separately and then combined with ‘OR’):
[(brain training” OR “memory training” OR dual tasking OR dual-task OR “mental
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activity” OR “mental training” OR brain exercise OR brain exercises OR “cognitive
training” OR "computer based cognitive training" OR “computerized brain training” OR
psychoeducation OR square stepping exercise OR neuropsychological performance)
AND
(vascular OR blood pressure OR artery OR arteries OR cerebrovascular OR
neurovascular OR cardiovascular OR “blood flow” OR “arterial compliance” OR blood
vessel OR blood vessels OR “carotid artery” OR VO2max OR “arterial stiffness” OR
blood flow velocity OR “heart rate” OR “pulse pressure” OR “aerobic fitness” OR
“vascular mechanics” OR “peripheral circulation” OR vascular stiffness)
AND
[(“older adult” OR “older adults” OR seniors OR 55+ OR mild cognitive complaint OR
cognitive complaint OR mild cognitive complaints OR cognitive complaints, OR senior
OR aged OR geriatrics)]
Study Selection
One researcher independently reviewed the title, abstract or description of all trials
identified by the literature search. For level 1 screening, the eligibility criteria were kept
broad, as outcomes are often poorly reported in titles and abstracts. Studies that aimed to
conduct CT in individuals over the age of 55 years were selected. The eligibility criteria
were stricter for full-text review and the type of CT intervention, outcomes reported, and
study designs were scrutinized to determine if they met the inclusion criteria.
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Data Extraction
Two independent researchers extracted data from included studies using standardized
extraction forms. Discrepancies were resolved by discussion until a consensus was
reached. Data items collected included: study characteristics (i.e. type of intervention,
location, length of study, recruitment), subject characteristics (i.e. age, gender, race,
education, eligibility, inclusion and exclusion criteria), primary and secondary outcome
results (if CV variables were present), details of the CT intervention and comparator
group(s), statistical analysis (i.e. statistics used, power calculation), withdrawal and lost
to follow-up reasons. The presence or absence of the following comorbidities were also
documented: hypertension, dyslipidemia, diabetes, coronary artery disease,
cerebrovascular diseases, transient cerebral ischemic attack, coronary heart disease,
severe orthopedic limitations, and depression.
Quality Assessment
In order to determine the validity of eligible RCTs, two researchers independently
assessed the risk of bias in all of the included studies. The PEDro scale was used to
assess study quality and validity of the articles (pedro.org.au). The PEDro scale is an
accepted and reliable tool, determined to have sufficient reliability for its use in
systematic reviews of physical therapy RCTs61. The PEDro scale consists of an 11-item
scale with the final PEDro score is based on a maximum score of 10; Item 1, which
relates to external validity, is excluded from the final score. See Appendix A (Table 1)
for details of each item and scoring.
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Data Synthesis and Analysis
Data synthesis was conducted from a description of studies and qualitative synthesis of
findings; therefore, heterogeneity via a statistical approach was not conducted.
Altogether, studies used various forms of CT, length of intervention and outcomes; of
which only 2 had the same CV outcome; determined a priori that three studies would
need to assess the same outcome in order to conduct a meta-analysis.
RESULTS
Study Selection
The initial literature search identified 640 titles and abstracts, of which 73 were removed
for duplicate citations. Of the remaining 567, 556 (98.1%) were excluded because the
article: (1) did not explore CT in the context of vascular outcomes (97.4%); (2) did not
include any form of CT (88.1%); (3) did not compare CT to any alternative therapy
(87.1%); (4) did not screen out patients for dementia (75.2%); (5) did not include an
appropriate intervention and comparator (55.4%); (6) did not compare participants to at
least one confounding factor outlined (43.9%); and (7) included patients under the age of
55 years (26.3%). Of the remaining 11 articles, 7 (1.4%) of them were excluded because
the article: (1) was a protocol study (.35%); (2) was still on-going (.35%); and (3) did not
aim to explore CT in the context of managing vascular health (.70%). In total, four
studies were included in the systematic review, see Figure 1 for the CONSORT diagram.
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638 citations identified
through database
searching

2 additional citations
identified through other
sources

73 duplicate citations
removed

567 citation screen

556 (98.1%) citations excluded

(by title and
abstract)









98.6% did not aim to explore cognitive
training in the context of vascular health
55.4% did not include an appropriate
intervention vs. control program
26.3% patients were under 55 years of age
75.2% patients were not screened out for
dementia
88.1% did not include any form of
cognitive training
87.1% did not compare cognitive training
to any alternative therapy
43.9% did not compare participants to at
least one confounding factor outlined

11 full-text articles
assessed for eligibility
7 (1.4 %) citations excluded




.35% were still on-going studies; results
were not provided
.352% were protocol studies
.70% did not aim to explore cognitive
training in the context of managing
vascular health

4 studies included in
qualitative synthesis
Figure 1: CONSORT Diagram for Systematic Review
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Study Design and Study Quality
Study characteristics of the four included studies are presented in Table 3. All four
studies were published in English, with all but one study having an 8 week intervention
period. They all had a parallel group RCT design, and assessed for dementia using a
diagnostic tool or by subjective report. They all scored a 6, 8 or 9 out of a perfect score
of 10 on the PEDro scale of quality assessment, a valid measure of the methodological
quality in clinical trials70.
All four studies received a point on the PEDro scale for: (1) specifying their eligibility
criteria; (2) having similar groups at baseline regarding the most important predictive
markers; (3) measuring at least one key outcome of which was obtained from more than
85% of the subjects initial allocation to groups; (4) all subjects received the treatment or
control condition as allocated or, where this was not the case, data for at least one key
outcome was analysed by “intention to treat,” and (5) reporting the results of betweengroup statistical comparisons for at least one key outcome. All but one study provided
both point estimates (i.e. means) and variability measures (i.e. standard deviations) for at
least one key outcome.
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Table 3: Study Characteristic Details of Accepted Articles
Author, Study Dementia
Type of CT
Training Comparator
Covariates
Year
Design Diagnostic
Length
Group
Tool
Mozolic aRCT
MMSE score Non-computerized 8 weeks Went to lab and ----et al.,
within 2.5
Training, targeting
listened to
68
2010
SD of the
attention and
lectures/educati
mean for
distractibility
onal program
their age and projected on a
educational
movie screen
level
Shimzu
et al.,
201359

b

Fabre et
al.,
200222

a

Linde et
al.,
201469

b

RCT

RCT

RCT

Excluded
serious
medical
conditions
that may
interfere
with
participation
in study
(subjective
report)
BEC score
of 94.0 (.97)

Subjective
report

Movement music
therapy (MMT)
with Naruko
Clapper

8 weeks

Exercise with
counting and
no music

Age,
weight

Israel’s Method 8
Themes:
 perceptive
activities
 attention
 intellectual
structuration
 association and
imagination
 language
 spatial marks
 temporal marks
 associated
recruiting
Editing worksheets,
selected from CT
manual developed
& evaluated by
Oswald et al.

2
months

Leisure
activities
i.e. painting
and choral
singing

Age, body
mass,
height

16
weeks

Inactive
waiting control;
Standard or
usual care

CVD
regimen

Abbreviations: MMSE, Mini-Mental State Examination; CVD, Cardiovascular Disease; RCT, Randomized
controlled trial. aRCT: Parallel; bRCT: Factorial
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However, none of the studies received a point for blinding their therapists who
administered the therapy. Merely two studies received a point for blinding their subjects
(to group allocation only). Firstly, Linde and colleagues69 had the only study to receive a
point for having concealment of allocation, thereby avoiding systematic biases. Secondly,
Linde and colleagues blinded their assessors who measured at least one key outcome;
therefore giving their study the highest score on the PEDro scale of 9 out of 10, see Table
4.
Table 4: PEDro Scale
Item Scale

Mozolic et

Shimzu et

Fabre et

Linde et

al., 201068

al., 201359

al.,

al.,

200222

201469

Randomized

Yes

Yes

Yes

Yes

Concealed Allocation

No

No

No

Yes

Baseline Similarity

Yes

Yes

Yes

Yes

Subjects Blinded

Yes

Yes

No

No

Therapists Blinded

No

No

No

No

Assessors Blinded

No

Yes

No

Yes

Outcome from >85% of
Subjects
Intention-to-treat

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Between-group Statistic

Yes

Yes

Yes

Yes

Point & Variable Measures

No

Yes

Yes

Yes

Total Score

6

8

6

9

1 point given for yes, 0 points for no

Participants
The included studies contained 226 participants. The mean age of participants in the
control group across all studies ranged between 65-77 years old. Similarly, the
intervention groups had the same mean age range across all studies. Participant
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withdrawals from studies included: (1) scheduling restraints or MRI incompatibility; (2)
small amount of male enrollment; (3) health complaints; or (4) in some cases, were not
reported. All studies included community-dwelling older adults age 55 years or older
who were deemed healthy or cognitively impaired, no dementia through a diagnostic
assessment or subjective report. See Table 5 for subject characteristics details.
Cognitive Training
All four studies differed on their intervention. Mozolic and colleagues conducted an 8
week intervention using a non-computerized training program that targeted attention and
distractibility68. Participants had to supress irrelevant distractors (i.e. short video clips for
visual distraction or sound clips for auditory distraction) of people, places, and events
while completing tasks requiring detection, classification and/or sequencing visual or
auditory presentations of letters, words, and numbers (2-5 mins/task). An active control
group was required to attend lab and listen to educational programs68.
On the contrary, Shimzu et al., also conducted an 8 week intervention but used movement
music therapy (MMT) with a Naruko Clapper59. The Naruko is a musical instrument
made of an uncomplicated clapper mechanism. Participants were instructed to clasp the
Naruko and shake it, generating a clapping sound while coordinating with background
music.

23

Table 5: Subject Characteristic Details
Author,
Year

Study Total
Total
Withdrawal
Total
Total
Site
Eligible Female Reasoning
Analyze Analyze
(%)
(C)
(I)
cCS
66
55.3
Scheduling
25
23
Mozolic
constraints
et al.,
or MRI
201068
conflict
d

CS

124

100

Males
excluded
due to small
amount of
males

e

CS

32

-----

-----

CS

70

58.6

Logistic
issues,
health
complaints,
participation
in other
programs,
dislikes
intervention

Shimzu
et al.,
201359

Mean ±
SD Age
(C)
69.4±2.4

Mean ±
SD Age
(I)
69.3±3.2

33

58

76.3±5.0 76.5±4.6

8

24

65.7±1.5 65.9±1.4

13

42

66.7±3.2 67.2±3.3

Fabre et
al.,
200222
f

Linde et
al.,
201469

C: Control; I: Intervention. cCS: USA; dCS: Japan eCS: France; fCS: Germany

The clapper utilizes whole body movement, and is a beneficial exercise for flexibility of
joints and strengthening of limbs. The intervention included 5 steps: (1) verbal greetings,
(2) warm-up, (3) light exercises, (4) main exercise and (5) relaxation. The control group
performed the same exercises as the intervention group however; subjects did not have
music or operate the Naruko59.
For 8 weeks, the Israel method which targets 8 themes of cognitive function was
employed by Fabre and colleagues22. The session commenced with 15 minutes of
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explaining memory mechanisms followed by participants working according to the theme
of the session. The 8 themes included: (1) perspective activities (sight and hearing) such
as remembering details from pictures of people or objects and detecting a particular
sound in an auditory text, (2) Attentional activities required reading different texts and
summarizing the main idea, (3) intellectual structuration was stimulated by completing
word beginnings, (4) association and imagination activities such as finding hidden objects
in a picture or finding similar or differential areas in a picture of humans, animals or
objects, (5) language activities had to retrieve opposite or complementary words, (6)
spatial marked activities were stimulated by drawing the mirror image of different
objects, (7) temporal marked activities required ordering in chronological order the news
events or personal recollections, and lastly (8) associated recruitment was stimulated by
using personal dates (birthdays, anniversaries) to remember banking and social security
numbers. On the contrary, the active control group was required to perform leisure
activities22.
Lastly, the longest intervention of 16 weeks was executed by Linde and colleagues69.
Selected exercises from a CT manual developed by Oswald et al.24,71, were used. The
primary focus of the CT intervention required subjects to edit worksheets either alone,
with a partner or in a group. After a 5-minute short-term memory warm-up training, 25minutes were allocated to practicing: short-term memory, visuospatial skills, information
processing speed, concentration, and logical reasoning. At the end of each session, two
additional exercises were given as homework. This was the only study that had an
inactive, standard care control group69.
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Risk of Bias Across Studies
In order to exclude participants with dementia, various screening tools were used across
the four studies. Mozolic and colleagues used the Mini-mental state examination
(MMSE)68, a valid and reliable 30-point questionnaire which is commonly used in
clinical and research settings to measure cognitive impairment72. Two studies excluded
for dementia/serious medical conditions by subjective indication from the
participants59,69. The BEC 96 questionnaire was performed by Fabre and colleagues22. A
semantic and fluency task administered to participants to measure cognitive function and
detect cognitive issues66. All but one study had an active control group in their
study68,59,22. Generally the mean age of participants differed across all four studies. Two
of the studies had a mean age of mid 60’s22,69, whereas the remaining two studies had a
much older mean age of late 70’s68,59.
Outcome Measures and Intervention Effects
Cerebral Blood Flow (CBF)
Whole brain CBF was assessed in only one study68. However, due to insignificant
findings in whole brain CBF, regional blood flow was examined and a significant finding
in the right inferior frontal cortex (RIFC) and the mean group difference from pre-post
was found. Right inferior frontal cortex was observed following CT that involved a noncomputerized training program targeting attention and distractibility projected on a movie
screen. A significant increase (p<.05) of 15.6 ml/100·g/min (43.6 to 59.2 ml/100·g/min)
for the intervention group in RIFC was found. However, the control group, who listened
to educational programs in the lab, had a negative difference of 3.9 ml/100·g/min (58.1 to
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54.2 ml/100·g/min). Therefore, CT indicated a beneficial effect of the intervention
compared to the control group.
Clinical Systolic and Diastolic Blood Pressure (cSBP and cDBP)
Clinical SBP and DBP were assessed by Shimzu and colleagues59 after completing 8
weeks of training with (intervention group) or without (control group) the Naruko clapper
and music. The mean group difference from pre-post is presented. They found a
significant decrease in SBP of 8.48 mm Hg (134.86±19.40 to 126.38±15.64 mm Hg;
p=.004) in the intervention group and no change in the control group with a difference
between groups pre-post of p=.109. DBP had no change in intervention, control or
difference between groups.
Maximum Volume of Oxygen Consumption (VO2max)
Two studies examined changes in VO2max22,69. The first study was done by Fabre and
colleagues who had their participants complete the Israel method of eight themes22. Three
different intervention groups were observed: (1) AE training, (2) CT, and (3) combined
AE and CT and were compared to a control group that completed leisure activities (i.e.
painting, singing etc.). A significant increase in VO2max was found in two of the three
intervention groups. The AE training only group had increased the most out of all the
intervention and control groups , with a difference of 280 ml·min-1 (1350±510 to
1630±146 ml·min-1; p<.05). The combined intervention group had an increase of 115
ml·min-1 (1510±109 to 1625 ml·min-1±217 ml·min-1; p<.05). However, the mental
training only group decreased by 69 ml·min1 (1060±116 to 999±118 ml·min-1; p>.05). On
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the contrary, the control group had a very slight increase in VO2max of 11 ml·min-1
(1256±100 to 1265±115 ml·min-1; p>.05).
The second study was by Linde and colleagues69. They observed VO2max before and
after 4 months of editing worksheets, selected from a CT manual developed and
evaluated by Oswald et al24,71. Similar to the study by Fabre and colleagues, 3 different
intervention groups were used: (1) physical training, (2) CT, and (3) combined physical
training and CT and were compared to an inactive waiting/standard or usual care control
group. A significant increase in the physical training only group of 2.69 ml·min-1·kg-1
(25.19±8.44 to 27.88±6.25 ml·min-1·kg-1; p<.05) was observed. In the CT only group,
there was a clinically significant increase of 2.53 ml·min-1·kg-1 (25.41±7.73 to
27.94±8.30 ml·min-1·kg-1; p<.10).
Contrary to the findings of Fabre and colleagues, the combined intervention group was
the most successful with an increase of 4.52 ml·min-1·kg-1 (24.1±9.97 to 28.86±8.72
ml·min-1·kg-1; p<.01). Furthermore, in the control group, the two studies also differed.
The control group significantly increased the most by 5.13 ml·min-1·kg-1 (23.90±8.34 to
29.03±7.53 ml·min-1·kg-1; p<.001) compared to any of the intervention groups69. See
Tables 6 and 7 for control and intervention group results.
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Table 6: Control Group Results
Author, Year Control
Group

CV

Baseline

Follow-Up

Outcome

PValue

N

Mean SD

Time

N

CBFRIPC
(ml/100·
g/min)

25

58.1 -----

8
weeks

25

YE

SBP
(mm Hg)

21 134.6 15.3

8
weeks

21 135.1 10.6

pa = .89

OE

SBP
(mm Hg)

8

132.5 17.7

8
weeks

8

128.8 22.0

pa = .69

YE

DBP
(mm Hg)

21

78.5 11.2

8
weeks

21

76.9

8.4

pa = .49

OE

DBP
(mm Hg)

7

70.4

9.3

8
weeks

7

70.1 20.0

pa = .96

Fabre et al.,

VO2max

8

1256 100

8

1265 115

p >.05

200222

(ml·min-1)

8
weeks

Linde et al.,

VO2max
(ml·min-1
·kg-1)

13

23.9

16
weeks

13

29.0

pa<.01*

Mozolic
et al., 201068

Shimzu
et al., 201359

201469

8.3

Mean

SD

54.2 -----

7.5

-------

Control YE: Control younger elder; Control OE: Control older elderly; CBF-RIPC: Cerebral Blood Flow in right inferior prefrontal
cortex.
Pa: Paired t test, compared before and after in each group; p=/<*: significant
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Table 7: Intervention Group(s) Results
Author,

Intervention

CV

Year

Group

Outcome

Baseline

et al.,

Attention
CBF-RIPC
and
(ml/100·g
distractibility tissue/min)

PValue

N Mean

Mozolic

Follow-Up

23

SD

Time N

Mean

SD

43.6 -----

8 23
weeks

59.2

----- p <.05*

201068
YE

SBP
(mm Hg)

32 140.1 17.7

8 32
weeks

129.0

15.3 pa = .00*

OE

SBP

26 128.5 19.8

26

125.2

17.1 pa =
.434

YE

DBP

32

76.4 8.7

32

73.1

9.2

pa = .05*

OE

DBP

26

66.9 12.6

26

65.9

8.9

pa = .613

1630

146 p<.05*

Shimzu
et al.,
2013

59

8 1350

510

8 8
weeks

VO2max
(ml· min-1)

8 1060

116

8

999

118 p>.05

Aerobic +
Mental
Training

VO2max
(ml· min-1)

8 1510

109

8

1625

109 p<.05*

Physical
Training

VO2max
(ml·min-1
·kg-1)

15

25.2 8.4

16 15
weeks

27.9

6.3

pa = .02*

Cognitive
Training

VO2max
(ml·min-1
·kg-1)

11

25.4 7.7

11

27.9

8.3

pa = .05*

Physical +
Cognitive
Training

VO2max
(ml·min-1
·kg-1)

16

24.1 10.0

16

8.7

pa = .01*

Fabre et

Aerobic

VO2max

al.,

Training

(ml· min-1)

200222

Mental
Training

Linde et
al.,
201469

28.9

Intervention YE: Intervention younger elder; Intervention OE: Intervention older elderly; CBF-RIPC: Cerebral Blood
Flow in right inferior prefrontal cortex; Pa: Paired t test, compared before and after in each group; p=/<*: significant
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DISCUSSION
This systematic review examined the effects of cognitive training on vascular health in
community-dwelling older adults who were either healthy or cognitively impaired. Four
articles qualified for qualitative analysis, demonstrating the paucity of research in this
field. The eligible studies were published within the past 13 years (2002-2015),
signifying the effects of CT particularly on vascular health in older adults is still in its
nascent stage. However, this review still offers direction for research and health care
systems about specific modalities that have been tried and found to be successful.
Mozolic et al.68, used non-computerized CT to significantly increase CBF, whereas
Shimzu et al.59, used music therapy to significantly decrease both SBP and DBP.
Although this review cannot definitively state CT interventions are paramount due to
limitations in study design, the studies included in this review and others who did not
meet the review criteria but still included CT73,74 have found significant improvement on
vascular health.
Furthermore, CVRFs also implicate cognitive function, especially as we age. An editorial
in the American Medical Association concluded that the most readily adjustable risk
factors of dementia were vascular risk factors53. Fukuhara and colleagues explained a
possible correlation between atherosclerosis and cognitive impairment whereby
preventing the occurrence of atherosclerosis would in turn prevent cognitive
impairment45. Several longitudinal studies including a one-year study with a nondemented elderly population with subjective memory complaints was founded to have a
decline in their MMSE score due to heightened aortic stiffness75. Such findings were
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replicated in the PARTAGE study76, the Baltimore Longitudinal Study of Aging14 and
The Health ABC sub-study38. Similar outcomes were found among late-life blood
pressure and cognition where two studies supported the idea of a “U” shaped association
concerning blood pressure and a decline in cognitive function37,77 . Nine studies also
confirmed the detrimental effect of high blood pressure (SBP>150 mm Hg) on cognitive
function33-35,78-83. Therefore, it is imperative to find a definitive prevention strategy or
moderator for CV health which will in turn preserve cognitive function, particularly in
the older adult population.
Study Limitations
Mozolic et al., demonstrated a significant impact of CT on CBF in older adults, despite
being a small pilot study. The addition of a younger population as a control group could
verify whether training-induced changes are specific to older adults or could be used for
younger adults as well68. The Naruko Clapper and music therapy study lowered clinical
blood pressure which could be due to the division of their sample into younger and older
elderly groups. Furthermore, they encountered a comparatively high dropout rate due to
the length of the intervention and traveling distance to test locations and should be
addressed in future studies59. Fabre and colleagues found significant improvements in
VO2max in two of the three intervention (combined AE and CT; and AE training only)
groups. They raised a very important variable, anxiety in older adults, to be a possible
determinant for the lack of improvement in the mental training group alone22. Elderly
subjects in general are more anxious compared to younger individuals, which can be due
to a loss of attention span84. Increased energy in the elderly is required in order to match
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the performance of a younger adult; as a result, evidence has shown AE to alleviate
anxiety82. Therefore, groups involving AE diminish anxiety which could lead to better
performance compared to mental training alone and should be considered a variable to
control, if possible, in future studies22. Lastly, Linde et al., found a significant
enhancement in control and all intervention groups for VO2max. However, their
methodology could be attributable to their impact in VO2max. For economic reasons, a
field test was used to estimate VO2max, while still within a valid and acceptable range,
field tests can lead to bias by test practice or effects of motivation23. Consequently, the
increase in cardiovascular fitness among all groups can be partially accredited to either
one or both effects. Future studies should utilize undeviating methods to examine
cardiovascular fitness69.
Limitations of this review should also be noted. A second review for level 1 screening
was not completed due to time constraints. Moreover, initial study screening with title
and abstract may lead to limitations with identifying potential intervention studies despite
including articles for full-text review when uncertain about the title or abstract. In
addition, one article remained included even though clarification was needed about their
study population52. Complete data extraction for level 2 screening was not done by the
second reviewer because a meta-analysis was not possible based on the results of this
review. Lastly, limitations were set to citations published in English and articles from
year 2000 onwards, in order to confine the degree of the search yield to a manageable
amount of articles; therefore, some could have been missed.
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CONCLUSION
Overall, the present review examined the possible effects of CT on vascular health in
community-dwelling older adults who were either healthy or suffered cognitive
impairment but no dementia. Two of the four articles eligible for qualitative synthesis
demonstrated the affirmative effects of CT on vascular health (i.e. SBP and DBP);
however, the other two articles revealed a paradoxical impact on vascular health. It still
remains unclear whether CT is as favourable other methods for improving vascular health
(i.e. aerobic exercise or physical activity), which in turn may improve cognition. Future
studies should elicit the most pragmatic method of CT and add to the evidence base
regarding whether CT can improve vascular health in older adults.
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Thesis Objective
The purpose of this thesis is to elucidate whether a 6-month multiple modality mindmotor (M4) exercise program elicits similar effects on clinical resting systolic blood
pressure (SBP) and diastolic blood pressure (DBP), and 24-hour ambulatory systolic
blood pressure (24-Hr SBP) and diastolic blood pressure (24-Hr DBP) in communitydwelling older adults (aged 55 years and older) with subjective memory complaints,
compared to a 6-month multiple modality (M2) exercise program administered alone.
Secondary objectives
1) Investigate whether M4 improves 24-hour, daytime, and nighttime peak systolic
blood pressure (sbppk); peak diastolic blood pressure (dbppk); heart rate (HR);
common carotid arterial stiffness [(intima-media thickness (IMT) and arterial
compliance (AC)]; blood flow velocity [systolic pulse wave velocity (Psv),
diastolic pulse wave velocity (Pdv), end-diastolic pulse wave velocity (Pedv) and
average pulse wave velocity (Pavg)]; and cardiovascular (CV) fitness (maximum
volume of oxygen uptake;VO2max), to a similar extent as M2.
2) Determine if age (younger elderly, YE; versus older elderly, OE) has an impact
on the improvement of vascular health (24-hour ambulatory and clinical resting
blood pressure (BP), arterial stiffness, blood flow velocity and cardiovascular
fitness) between M2 and M4.
3) Establish whether a difference exists between sex and vascular health (24-hour
ambulatory and clinical resting BP, arterial stiffness, blood flow velocity and
cardiovascular fitness) improvement among M2 and M4.
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Hypotheses
The M4 and M2 group will have similar improvements in 24-hour ambulatory and
clinical resting SBP and DBP.
Secondary Hypotheses
1) 24-hour, daytime and nighttime sbppk, dbppk, HR, carotid IMT and AC, Psv, Pdv,
Pedv, Pavg and VO2max will all improve to a similar extent in both M2 and M4
groups
2) The YE adults will have greater improvements in vascular health (blood pressure,
carotid IMT, carotid AC, VO2max and blood flow velocity) compared to older
adults in both M2 and M4
3) Females will have greater improvements in vascular health (blood pressure, carotid
IMT, carotid AC, VO2max and blood flow velocity); compared to males in both
M2 and M4 groups
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Chapter 3: Methods
Subjects
Participants were recruited through various newspaper ads and flyers in local
establishments, including doctor’s offices in Woodstock, ON. Individuals considered for
this study were 55 years of age or older who had a subjective cognitive complaint
including memory or thinking skills and preserved instrumental activities of daily living
[based on the Lawton-Brody Instrumental Activities of Daily Living (IADL) scale85].
Participants were excluded if they (1) were self-reported or suspected to have dementia
(i.e. MMSE score <24); (2) had other significant neurological or psychiatric conditions
(i.e. Parkinson’s disease, Bipolar disorder, Schizophrenia etc.); (3) severe sensory
impairment (i.e. blind); (4) previous history of severe CV conditions in the past 2 years
(i.e. myocardial infarction, end stage congestive heart failure, end stage renal disease,
stroke etc.); (5) significant orthopedic conditions (i.e. severe arthritis); (6) blood pressure
<180/100 mmHg or <100/60 mmHg; (7) major depression [based on CES-DS (score
≥16)] and clinical judgement of primary physician; (8) unable to comprehend
questionnaire material; and (9) any other reason that would impact ability to fully take
part in intervention (i.e. cannot commit to approximately 80% of exercise sessions).

All participants gave written informed consent. The study was approved by Western
University Research Ethics Board for Health Sciences Research Involving Human
Subjects (Appendix D), Lawson Health Research Institute Research Ethics Board
approval by CRIC to utilize hospital resources from Parkwood Hospital (Appendix E),
Clinical trial protocol was registered at clinicaltrials.gov (Appendix F).
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Study Design
Screening Assessment
Participants underwent a screening assessment. Concurrent medical conditions given
verbally, medical history, medications and three seated blood pressure (BP)
measurements were collected (Omron Healthcare, Automatic Blood Pressure Monitor,
Model 1A2, Japan). Questions were asked regarding their memory and thinking skills
prior to assessing their cognitive function using standardized questionnaires including the
Mini Mental State Examination (MMSE)86, the Montreal Cognitive Assessment
(MoCA)87, and an assessment of their ability to engross in daily activities using the
IADL85. The determination of whether individuals suffered from depression was
examined through the Center for Epidemiologic Studies: Depression Scale (CES-DS)88.
If found to have severe untreated depression (score over 16/60), their family physician
was contacted for further information and consultation with the primary investigator, Dr.
Petrella to determine best course of action.

Eligible Participants
Eligible participants completed a 3-day baseline assessment prior to commencing the 6month exercise classes. Similarly, the 3-day assessment was conducted at the end of the
6-month intervention period. The first two days of assessments took place at Salvation
Army Church (Woodstock, ON) and the third day took place at the Aging, Rehabilitation
& Geriatric Care (ARGC) Research Centre located in the Parkwood Institute (London,
ON). On the first day, participants were asked a few questions regarding their general
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health and current level of physical activity using the Phone-FITT questionnaire89.
Subjects were then introduced to Cambridge Brain Sciences (CBS), a computer-based
cognitive battery (www.cambridgebrainsciences.com). The information retrieved from
the 12 computer games targeted specific domains of cognitive function including
memory, concentration, reasoning and planning (see Appendix B, Table 1 for description
and scoring rubric). On the second assessment day, participants played the 12 computer
games in their entirety and their results were recorded. On the third day, participants
underwent a series of measurements including: i) vascular measures: 24-hour ambulatory
BP (SpacelabsTM ABPM, Model 90207, Spacelabs Inc., Redmond WA, USA), clinical
resting BP with an automated oscillometric monitor (BP was measured (BpTRUTM, VSM
MedTech Ltd., Coquitlam, BC), and a carotid artery ultrasound (2-D Ultrasound; GE
Vingemed System 5); ii) gait and mobility using the reliable and validated GAITRite
system (platinum version)90, which uses a sensory walkway mat connected to a software
to record spatio-temporal gait characteristics; and iii) sensorimotor eye-tracking
assessment (EyeTrac6: Applied Sciences Laboratories, Bedford MA) measuring anti- and
pro-saccade reaction time and errors.
Cardiovascular Assessments
Only the measurements used in this thesis will be described in detail below.

24-Hour ambulatory blood pressure
At the end of day 1 or day 2 assessments, participants were fitted with a 24-hour
ambulatory BP monitor. The monitor was worn once at baseline and at the end of the 6month intervention. Ambulatory BP measures consisted of average 24-hour, daytime and
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nighttime SBP, DBP, sbppk, dbppk, mean arterial pressure (MAP) and heart rate (HR)
recordings. The monitor took a total of 40 readings over the 24-hour period. One
measurement was taken every half hour during the day between 06:00-22:00, and one
measurement was taken every hour from 22:00-06:00. The monitor gave a five second
warning beep as an indicator to the participant to relax their arm prior to inflation of the
cuff. The monitor beeped once to indicate completion of a successful measurement or
beeped repeatedly to indicate an error. In case of measurement error, the cuff
automatically inflated two minutes later in an attempt to obtain a successful measure.
Participants were asked to not shower during the 24-hour period in order for the cuff to
remain on their arm for the entire 24-hour period.
A BP diary was also given in order for each participant to record any events that could
cause their BP to increase (i.e. stressful event, laughing hysterically, exercising, etc.).
First participant asked to wear for another 24 hours where possible. Average SBP, DBP,
peak SBP and DBP, MAP, and HR for daytime, nighttime and an overall 24-hour
summary were recorded along with hourly readings. The cut-off for an adequate amount
of readings was 50% (20 successful readings) for statistical analysis, otherwise the
participant was asked to wear the monitor for another 24 hours.
Ambulatory BP measures give an accurate sense of how the participant’s BP fluctuates
throughout the day. More readings are taken throughout the day than at night because that
is the time when the participant is more active/mobile. Therefore, taking more frequent
measures of BP during the day will give a more accurate depiction of the participant’s
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BP. Nighttime BP was taken less frequently due to the fact that older adults are more
sedentary at night.
Clinical Resting BP
Clinical resting BP is comparable to measures of what a participant would take if done
themselves or at a doctor’s office. On the third assessment day, participants reported to
the laboratory (Aging, Rehabilitation and Geriatric Care Research Centre, Parkwood
Hospital, London, Ontario, Canada) after abstaining from vigorous exercise (for 24
hours), alcohol (for 24 hours), caffeine (for 12 hours), smoking (for 12 hours) and fasted
for a minimum of four hours prior to their appointment to standardize each participant
prior to their ultrasound91. A BP cuff was secured around the left upper arm (unless
contraindicated by other medical issues) approximately two centimeters proximal to the
antecubital fossa. After five minutes of seated rest, with back and arms supported and feet
flat on the floor, three brachial artery SBP, DBP and HR were measured in triplicate with
two minute intervals between cuff inflation91.. The averages of the last two measurements
were used in analysis. Participants were instructed to relax and remain still and quiet
throughout the duration of BP measurements.
Carotid artery intima-media measurement
Following BP measurements, a common carotid artery ultrasound was performed. The
carotid artery is an ideal area as it is superficial, easy to access and covers the aorta that
demonstrates the greatest age-related stiffening92. In almost all cases with few exceptions,
the same investigator was used to perform all carotid artery ultrasounds at baseline and 6months. A second investigator performed the ultrasound at random in order to examine
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inter-rater reliability. A checklist was completed with each participant preceding the
ultrasound, ensuring the participant followed instructions regarding no exercise, alcohol,
caffeine, smoking or food. If deviated, a note was made on the checklist of what they ate
or did and what time it occurred in reference to their ultrasound appointment. The
participant was left to lay supine on the bed for ten minutes to regulate their blood flow
velocity prior to connecting them to an electrocardiogram (ECG) to monitor their beat-tobeat HR. Two electrodes were placed two finger-widths below the clavicle, one 12 cm
left of the sternum and the other, 12 cm to the right of the sternum. A third electrode was
placed two finger-widths above the participant’s right ilium.
The right common carotid artery was imaged in all participants with their heads turned
approximately 45º towards the left. A 10 Mhz transducer was placed longitudinally
along the right common carotid artery to obtain two-dimensional B-mode ultrasound
images (Vingmed System 5, GE Ultrasound A/S, Horton, Norway). Image
standardization of the carotid artery was done whereby all measurements were taken 2-4
cm away from the carotid artery bulb. Minimum diameters (diastolic), measuring from
wall to wall (vessel diameter) commonly coincided with the QRS peak on the ECG.
Maximum diameters (systolic) were measured from the top of the wall to the outer
edge/bottom of the endothelial layer, which commonly coincided with the T peak on the
ECG, however sometimes this had to be done through visual inspection as minimum and
maximum diameters did not occur according to the ECG. Averages of 3 values for
systolic and diastolic were used for carotid AC calculations, by which carotid AC was
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determined by using the following equation:
Carotid AC = ∆D/∆P
Carotid AC = [π(

𝐷𝑚𝑎𝑥 2
)
2

(Equation 1)
− π(

𝐷𝑚𝑖𝑛 2
) ]/∆P
2

where ∆D is the change in arterial diameter from systole (Dmax) to diastole (Dmin), and ∆P
is the tonometrically-obtained arterial pulse pressure93-95.
Carotid IMT was measured on a frozen-frame image, which was magnified to achieve a
higher resolution of detail and accuracy. Carotid IMT was measured by the subtraction of
the lumen diameter from the arterial diameter, which resulted in the thickness of
endothelium in millimeters. Carotid IMT was obtained from three contiguous sites within
a 2 cm range, the mean of these values were used in statistical analysis96. Normative
values for carotid IMT for ages 50-59 years is 0.85, while adults 60 years or more
generally have an IMT of 1.0597.
Carotid artery blood flow velocity measurement
Blood flow velocity looks at the rate at which blood flows through the artery to and from
the heart and the brain. Selecting “pulse wave” on the ultrasound machine, allowed a
different view on the monitor that required the adjustment of “velocity range” and the
angle at which blood is flowing. The shorter the velocity range, the larger the signal.
Doppler ultrasound was used to collect the pulse wave for 60-72 seconds. Three
consecutive pulse waves were chosen based on similar image properties among them.
Output recorded for statistical analysis included peak systolic velocity (Psv), peak
diastolic velocity (Pdv), end-diastolic velocity (Pedv) and average velocity (Pavg).
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Normative values for blood flow velocity in the common carotid artery for adults aged
60-85 years98.
Once the ultrasound component was completed, participants continued to lie on the bed
as a supine brachial artery BP measurement was done once by placing the same BP cuff
and monitor used for clinical resting BP measures. Participants were offered a
standardized snack (granola bar and juice box) upon completion of the ultrasound.
CV Fitness (VO2max)
The last CV assessment was a step test, which was completed at baseline, half-way
through the intervention at 3-months and at 6-months. The step test required the
participant to climb up-and-down two sets of stairs 20 times while timed with a stopwatch. This assessment was used to determine the predicted VO2max for the participant
and also provide a target heart rate for when they attended the exercise class. The
equation used to calculate VO2max through Microsoft Excel was the following:
𝑚𝑙
𝑘𝑔

(𝑠𝑒𝑥 ×10)

𝑉𝑂2 max ( 𝑚𝑖𝑛 ) = 𝑉𝑂2 (220 − 𝑎𝑔𝑒 − 73 − 𝐻𝑅−73−(𝑠𝑒𝑥 ×10)

𝑚𝑙
𝑘𝑔

𝑉𝑂2 max ( 𝑚𝑖𝑛 ) =

1.8×𝑤𝑜𝑟𝑘 ℎ𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 ×𝑠𝑒𝑥

where HR is the heart rate at final stage, 0 represented for men and 1 represented for
women99.
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Randomization
At the end of day 3, the randomization sequence was generated by one of the study
investigators; and the coordinator was concealed to allocation (used numbered, opaque
envelopes) using a randomization function (RANDBETWEEN) in Microsoft Excel.
Assessors were blinded to group allocation.
Exercise Intervention
Both exercise groups were led by seniors fitness instructors who were certified through
the Canadian Centre for Activity and Aging (CCAA). Each exercise session was 60minutes in length, conducted 3 times a week for 6 months (see Table 1 for Intervention
details).

Multiple Modality (M2) Exercise only group
The multiple modality (M2) exercise is a standard combined fitness class for older adults
and was developed and guided by the CCAA classes (www.uwo.ca/actage). The M2 only
group was structured to receive: 1) 5 minute warm-up targeting major joints and slowly
increasing heart rate, 2) 20 minutes of moderate to vigorous intensity aerobic exercise as
defined by ACSM guidelines for older adults100, 3) 5-minute cool-down to safely
decrease heart rate, 4) 10 minutes of resistance training of all major muscle groups
including core strengthening exercises, 5) 15 minutes of balance training and, 6) 5
minutes of stretching.
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Multiple Modality Mind-Motor (M4) intervention group
The M4 group was similar to the M2 group except modified to incorporate 15 minutes of
mind-motor exercise. The mind-motor exercise component is best described as a
visuospatial working memory task, with a stepping response. It is a low-cost, indoor
exercise program (i.e., Square Stepping Exercise (SSE)) originally designed to improve
balance and lower extremity functioning in older adults101. The SSE utilizes a floor mat
grid. In order to successively advance across the mat (motor task), participants were
required to memorize stepping patterns which get progressively more complex
(visuospatial working memory task) [see Appendix B. Table 2]. Both groups were
designed to have the same duration and similar exercises in order to control for
socialization and activity in general.
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Table 1: Intervention Details
M2: Multi-Modality Exercise
(Exercise Control)

M4: Multi-Modality, Mind-Motor
(Exercise Intervention)

Warm-up (5 minutes)
o Light aerobics
o Dynamic range of motion of the major
joints

Warm-up (5 minutes)
o Light aerobics
o Dynamic range of motion of the major
joints

Aerobic Exercise (20
Minutes)
o Large rhythmical endurance activities
(e.g., walking, marching, sequenced
aerobics)
o Keep HR continuously in target zone
(i.e. not interval training)
o Moderate to vigorous intensity
Rating perceived exertion (RPE): 5-8
on scale of 0-10
Participants to check HR ½ way through
and at end of aerobic exercise.
Participants will record final RPE and HR.

Aerobic Exercise (20 Minutes)
o Large rhythmical endurance activities (e.g.,
walking, marching, sequenced aerobics)
o Keep HR continuously in target zone
(i.e. not interval training)
o Moderate to vigorous intensity
Rating perceived exertion (RPE): 5-8
on scale of 0-10
Participants to check HR ½ way
through and at end of aerobic
exercise. Participants will record
final RPE and HR.

Aerobic Cool Down (5 minutes)
o Safely bringing heart rates down

Aerobic Cool Down (5 minutes)
o Safely bringing heart rates down

Resistance Training (10 minutes)
o Therabands, wall or chair exercises,
core strengthening
o Day 1 – Upper body focus
o Day 2– Lower body focus
o Day 3 – Core focus

Resistance Training (10 minutes)
o Therabands, wall or chair exercises, core
strengthening
o Day 1 – Upper body focus
o Day 2 – Lower body focus
o Day 3– Core focus

Balance & Sham Training (15
minutes)
o Keep HR BELOW target zone
o Dynamic, static and functional
balance
o Breathing and relaxation exercises
o Finger exercises
o Range of motion (e.g., arm circles)
Stretching (5 minutes)

Mind-Motor Training (15 minutes)
o Keep HR BELOW target zone
o Square Stepping Exercise (SSE)

Stretching (5 minutes)

TOTAL: 60
minutes
60 min Multi-Modal Exercise
Training

TOTAL: 60
minutes
45 min Multi-Modal Exercise Training
15 min Mind-Motor Training

Table created by: Gill, DP and Stuckey M, M4 Grant study protocol submission.
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Statistical Analysis
This study is built off of a larger study whereby a proposed 130 participants (65
participants per group) was an agreeable sample size. The sample size calculation was
based on the primary outcome, cognition, with 80% power at the 5% significant level to
detect an effect size of 0.55102,103. A subsample of the data was collected for the purpose
of this study, to examine secondary outcomes; therefore analyses were exploratory. A
sample size calculation using GPower 3.1 free software, was performed after the study
was completed, with 80% power at the 5% significant level to detect an effect size of
0.65. The primary outcomes of interest for the current study were difference between
groups in the following variables: 24-hour SBP, 24-hour DBP, clinical resting SBP and
DBP, after the M2 and M4 exercise intervention.
An independent t-test was utilized to assess any baseline differences between group (M2
and M4), age (YE and OE), and sex (male and female). Continuous variables were
checked per approximately normal distribution prior to statistical tests. All mean change
score outcomes were visually inspected for normality through histograms and the Shapiro
Wilks statistic. Data are conveyed as mean±standard deviation (SD), unless otherwise
stated. An ANCOVA was used for all mean change outcomes. Outputs recorded from the
analyses were estimate mean change, 95% confidence intervals (95% CI) and p-values.
Each outcome was a separate analysis. Group was the fixed factor and baseline was
adjusted for the outcome of interest. Two sensitivity analyses were conducted for each
outcome: 1) analyses were stratified for age and sex and created a separate stratum, and
2) analyses were restricted to all-completers (i.e., 41 participants). Interpretation is based
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primarily on point estimates and 95% confidence intervals (CIs). All statistical tests had
significance set at p<.05. SPSS for Windows (Version IBM SPSS Statistics 20) was used
to perform all statistical analyses.
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Chapter 4: Results
The results are divided into three sections. The first section focuses on all CV outcomes
compared by group (M2 vs. M4). Although the gold standard is to include all participants
randomized regardless of compliance (intent-to-treat) which balances known and
unknown confounders, at the end of the section, a table with compliant participants
(80%+) only are included to view the impact of the actual intervention. The second
section focuses on all CV outcomes compared by group and age. The last section focuses
on all CV outcomes compared by group and sex.
4.1 Descriptive Measures
Overall, 122 participants inquired about the study however, 33 participants were
excluded: 1) 23 participants were deemed eligible however; they declined to participate
in the study because of time commitment or personal issues; 2) 10 participants were
ineligible due to the study’s specific criteria including: i.2 participants did not have a
cognitive complaint; ii. 5 participants had a significant neurological or
neuropsychological condition (i.e. Bipolar Disease, Dementia, Alzheimer’s disease); iii. 1
participant scored less than 24 on the MMSE; iv. 1 participant had extreme hypertension,
greater than 180/100; v. 1 participant had severe depression (scored 41/60).

A total of 89 participants were recruited and assessed at baseline (27 males, 61 females)
which were included for baseline characteristics, however 4 participants with baseline
data dropped out during the intervention. See Figure 1 for consort diagram.
From the 89 participants recruited, 74 participants completed the study however, only 41
participants adhered to a minimum of 80% attendance (absent for a total of 14 classes or
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less) for the exercise classes. 33 individuals did not meet the 80% compliance however
their data was still used in statistical analyses. Deviations from compliance were due to
scheduled vacations, medical surgeries or personal reasons.
Demographics and medical history are located in Table 1 by group (M2 compared to
M4).
The M2 group contained 41 participants, whereas the M4 group had 48 participants. The
M2 group’s average age of 66 years was younger by one year compared to the M4 group
respectively. Majority of the participants were Caucasian with the exception of 2 African
Americans and 1 participant classified as ‘other’ ethnicity. More than half of the
participants were married in both groups and had the same years of average education (14
years) received. BMI was nearly the same between the two groups with M2’s mean BMI
of 30.26 and M4’s mean BMI 29.14. It is suggested by MedlinePlus, older adults should
have a BMI slightly higher (between 25-27) as oppose to under 25, due to potential
protective factors such as osteoporosis (nlm.nih.gov/medlineplus/osteoporosis.html).
More than half of participants drank alcoholic beverages on a weekly basis in both
groups, with each group having one person who smoked concurrently. Two assessments
were used to determine whether any cognitive impairment existed. The first assessment
was the Mini-Mental State Examination (MMSE), and the second assessment was the
Montreal Cognitive Assessment (MoCA), by which both had a maximum score of 30.
The average scores were nearly the same for both groups on the MMSE (mean score of
29), and MoCA (mean score of 25). An MMSE score of <24 indicates an increased odds
of dementia, a range of 24-30 has very little severity and translates to no cognitive
impairment86. A MoCA score of 26 or greater is considered normal for older adults135,
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therefore, our study population scored high on the MMSE but had an average score on
the MoCA, just below the accepted range, indicating some display of cognitive
impairment.
Medical history and medication was documented, specifically any cardiovascular
medication or medications that influence the cardiovascular health. A total of 49
participants were diagnosed by a physician as hypertensive, with 31 individuals who
were medicated. In total, 34 participants were diagnosed with high cholesterol, but only
22 participants were treated with medication. There were 8 participants with diabetes;
however, only 7 of them were medicated. A total of 13 participants reported having heart
trouble with all of them treated for with medication including blood thinners, heart or
other CV medication.
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Figure 1: Consort Diagram
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Table 1. Demographics and Medical History by Group
Characteristic
M2 (n = 41)
Age, y, mean (SD)
66.90 (6.38)
Female Sex, No. (%)
31 (75.61)
Caucasian, No. (%)
40 (97.56)
Married, N (%)
24 (58.54)
Education, y, mean (SD)
13.61 (3.36)
BMI, mean (SD)
30.26 (6.57)
Drink alcoholic beverages, No.
25 (60.98)
(%)
Current Smoker, No. (%)
1 (2.44)
Former Smoker, No. (%)
19 (46.34)
MMSE score (max 30), mean
29.05 (1.18)
(SD)
MoCA score (max 30), mean
25.59 (2.56)
(SD)
Medical History
Hypertension, No. (%)
20 (40.82)
Total (n = 49)
12 (38.71)
Medicated, (n = 31)
High Cholesterol, No. (%)
16 (47.06)
Total (n = 34 )
8 (36.37)
Medicated (n = 22)
Diabetes, No. (%)
3 (37.50)
Total (n = 8)
3 (42.86)
Medicated (n = 7)
Other CV conditions (i.e. COPD), No. (%)
7 (53.85)
Total (n = 13)
3 (23.08)
Medicated (n = 13)

M4 (n = 48)
67.77 (7.46)
31 (64.58)
46 (95.83)
27 (56.25)
13.17 (2.70)
29.14 (4.09)
28 (58.33)
1 (2.10)
25 (52.08)
29.00 (1.20)
25.23 (2.81)

29 (59.18)
19 (61.29)
18 (52.94)
14 (63.64)
5 (62.50)
4 (57.14)
6 (46.15)
10 (76.92)

Abbreviations: BMI, body mass index; MMSE, Mini-Mental Status Examination; MoCA, Montreal
Cognitive Assessment; pVO2max, Predicted Maximal Oxygen Uptake; a Data were missing for pVO2max
score in 2 participants and for body mass index in 1. Percentages are calculated excluding missing values
(where applicable). b Participants were asked to rate their memory on a scale of 5 (from much better to
much worse); cOther CV conditions Total was for heart trouble only due insufficient data for any other CV
conditions recorded, medicated individuals included blood thinners, heart or arterial medication

Baseline CV outcomes by group are presented in Table 2. All CV variables at baseline
were approximately normally distributed which were confirmed by normality tests. If
they were not significant, an appropriate log transformation would have been done to
normally distribute the data.
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Table 2: Baseline CV Outcomes by Group
Baseline CV Outcomes
Ambulatory BP
24-Hr Systolic BP
24-Hr Diastolic BP
24-Hr peak systolic BP
24-Hr peak diastolic BP
24-Hr MAP
24-Hr HR
Day Systolic BP
Day Diastolic BP
Day peak systolic BP
Day peak diastolic BP
Day MAP
Day HR
Night systolic BP
Night diastolic BP
Night peak systolic BP
Night peak diastolic BP
Night MAP
Night HR
Clinical Resting BP
SBP
DBP
Stiffness and Blood Flow
Carotid IMT
Carotid AC
Psv
Pdv
Pedv
Pavg
CV Fitness
VO2max

N

M2
Mean ± SD

N

M4
Mean ± SD

38
38
38
38
38
38
38
38
38
38
38
38
38
38
38
38
38
38

130.00 ± 14.35
74.37 ± 8.92
157.58 ± 17.48
95.84 ± 11.25
94.32 ± 9.99
71.68 ± 6.87
132.13 ± 14.34
76.11 ± 9.24
157.08 ± 18.24
95.74 ± 11.68
96.26 ± 10.24
72.84 ± 7.36
121.13± 16.48
66.74 ± 8.99
138.74 ± 17.01
80.66 ± 9.40
86.37 ± 10.54
66.68 ± 6.50

47
47
47
47
47
47
47
47
47
47
47
47
47
47
47
47
47
47

127.26 ± 11.73
72.98 ± 8.47
153.83 ± 17.51
92.83 ± 10.78
91.94 ± 10.06
71.57 ± 8.61
129.47 ± 11.58
74.85 ± 8.89
153.51 ± 16.00
92.83 ± 10.78
94.40 ± 9.06
72.87 ± 8.77
116.62 ± 20.37
65.53 ± 8.48
133.72 ± 17.49
77.28 ± 10.14
84.96 ± 9.34
66.55 ± 9.19

41
41

142.05 ± 19.24
83.00 ± 11.01

48
48

136.25 ± 17.05
81.29 ± 10.86

41
39
41
41
41
41

.69 ±.16
.83 ±.35
59.65 ± 17.07
17.11 ± 4.80
18.47 ± 5.20
29.96 ± 8.25

48
46
48
48
48
48

.65 ±.13
.90 ±.32
60.72 ± 14.65
16.92 ± 4.97
19.40 ± 8.48
30.48 ± 8.07

41

25.56 ± 8.38

48

27.44 ± 8.40

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings.
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4.2 Results by Group
Results between groups can be found in Table 3 and Figure 2. Only two CV outcome
variables, there was a significant difference between groups (M2 group was used as the
reference) from the ANCOVA analysis. Nighttime peak SBP, increased after the 6 month
intervention period compared to the M2 group. The mean group difference after 6months revealed an average decrease change of 6.55 mmHg (95%CI: -12.90,-.10; p=.04)
between the two groups. Clinical resting SBP also improved significantly more compared
to the M2 group. Between group difference revealed an average decrease of 6.99 mmHg
(95%CI: .60, 12.37; p=.03).
Although not statistically significant (p<.05), two blood flow velocity variables showed
clinical significance. Pdv showed trends towards worsening in the M4 group after the
intervention whereas Pedv showed improvement in the M4 group. Pdv between the two
groups, had an average decrease of 1.22 mmHg (95%CI: -2.59, .15; p=.09). The between
group differences for Pedv revealed a decrease by 1.22 mmHg (95%CI: -2.59, .15;
p=.08).
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Table 3: CV Outcomes Mean Change between M2 and M4 after 6 Months
CV Outcome Variables

Between Group Differences
Estimate
Mean ∆

Ambulatory BP
24-Hr Systolic BP
-.46
24-Hr Diastolic BP
.14
24-Hr peak systolic BP
-1.38
24-Hr peak diastolic BP
-1.74
24-Hr MAP
-.77
24-Hr HR
-1.01
Day Systolic BP
-.38
Day Diastolic BP
-1.17
Day peak systolic BP
-.08
Day peak diastolic BP
-.82
Day MAP
-.69
Day HR
-1.08
Night systolic BP
-1.92
Night diastolic BP
.29
Night peak systolic BP
-6.55
Night peak diastolic BP
-.12
Night MAP
1.11
Night HR
-1.42
Clinical Resting BP
SBP
6.99
DBP
2.82
Stiffness and Blood Flow Velocity
Carotid IMT
-.03
Carotid AC
.06
Psv
-3.24
Pdv
-1.26
Pedv
-1.22
Pavg
-1.90
CV Fitness
VO2max
.28

95% C.I
(lower bound, upper
bound)

P-value

-4.03
-2.16
-6.30
-6.08
-2.96
-3.81
-3.73
-6.76
-4.69
-.490
-3.37
-3.89
-6.53
-2.69
-12.90
-4.92
-1.99
-4.24

3.10
2.43
3.54
2.61
1.43
1.80
2.96
4.42
4.53
3.26
1.99
1.73
2.69
3.26
-.19
4.69
4.21
1.41

.80
.91
.58
.43
.49
.48
.82
.68
.97
.69
.61
.45
.41
.85
.04**
.96
.48
.32

.60
-.86

13.37
6.51

.03**
.13

-.08
-.04
-8.03
-2.71
-2.59
-4.26

.02
.16
1.55
.19
.15
.47

.17
.23
.18
.09*
.08*
.11

-1.70

2.26

.78

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05)
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Figure 2: Significant and Clinical Changes after 6 Months between Groups.
Effects of 6 months of M2 and M4 training on: (a) Night sbppk, nighttime peak systolic blood pressure (b)
Clinical resting SBP, clinical resting systolic blood pressure; (c) Pdv, peak diastolic velocity; (d) Pedv, enddiastolic velocity. Point estimates and 95%CI (confidence intervals; lower and upper bound) bars presented;
*clinical significance (p-value between .06-.09); **significant (p≤.05)

58

2

2.5

In the analysis with compliant participants (80 %+) included only, results indicate only
nighttime peak SBP had a significant decrease between group, which was similar to the
findings of the combined compliance and non-compliant participant analyses. The M4
group increased compared to the M2 group which decreased in nighttime peak SBP.
Conversely, in the compliant participants’ only analysis, the M2 group had a significant
positive reduction in carotid IMT compared to the M4 group which increased, see Table
4 for compliant only participants.
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Table 4: CV Outcomes Mean Change Between M2 and M4 with Compliant (80 %+)
Participants Only after 6 Months
CV Outcomes

Between Group Differences
Estimate 95% Confidence Interval
Mean ∆
(lower bound, upper
bound)

Ambulatory BP
24-Hr Systolic BP
-1.83
24-Hr Diastolic BP
.03
24-Hr peak systolic BP
-2.87
24-Hr peak diastolic BP
-5.58
24-Hr MAP
-.93
24-Hr HR
.31
Day Systolic BP
-2.06
Day Diastolic BP
-1.73
Day peak systolic BP
-2.66
Day peak diastolic BP
-2.54
Day MAP
-.98
Day HR
.15
Night systolic BP
-3.03
Night diastolic BP
-1.20
Night peak systolic BP
-11.54
Night peak diastolic BP
-1.73
Night MAP
.23
Night HR
.51
Clinical Resting BP
SBP
-.98
DBP
.03
Stiffness and Blood Flow Velocity
Carotid IMT
-.08
Carotid AC
-.01
Psv
-3.61
Pdv
-.97
Pedv
-1.31
Pavg
-1.25
CV Fitness
VO2max
.50

P-value

-6.46
-3.44
-11.03
-12.63
-3.34
-3.41
-6.84
-9.59
-10.26
-9.37
-4.46
-3,58
-10.05
-6.09
-22.46
-10.00
-5.88
-3.46

2.91
3.50
5.29
1.48
1.49
4.02
2.71
6.13
4.94
4.29
2.50
3.87
3.99
3.69
-.62
6.54
6.34
4.49

.43
.99
.48
.12
.44
.87
.39
.66
.48
.45
.57
.94
.39
.62
.04**
.67
.94
.79

-8.69
-4.61

6.73
4.68

.80
.99

-.15
-.14
-9.96
-2.76
-3.06
-4.28

-.01
.13
2.74
.82
.43
1.79

.03**
.95
.26
.28
.14
.41

-2.34

3.34

.72

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. **significant (p≤.05)
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4.3 Results within Age by Group
For further analysis, groups were separated and analyzed by “younger” elderly (YE) and
“older” elderly (OE) as determined by the data given on age. When stratified by age and
group, analyses within YE and within OE between groups revealed different significant
CV outcomes. When the YE were analyzed by between group effects, Pedv decreased by
an average of 2.17 (95%CI: -4.42, .08; p=.05), however the improvement was seen in the
M2 group not in the M4 group, see Table 5 and Figure 3.
The OE group only had a significant change in three ambulatory BP variables: 24-hour
HR, daytime HR and nighttime peak SBP. 24-hour HR decreased in both groups however
the M2 group further decreased compared to its counterpart. Between group difference
for 24-hour HR in the OE revealed a mean difference of -4.86 (95%CI: -9.26, -.47;
p=.03). Daytime HR increased in the M4 group compared to the M2 group which
decreased. The mean difference in daytime HR for the OE, between groups was -4.84
(95%CI: -9.24, -.44; p=.03). Lastly, nighttime peak SBP decreased in the M2 group but
increased in the M4 group. The between group mean difference in nighttime peak SBP
for OE was -11.24 (95%CI: -21.13, -1.34; p=.03), see Table 6 and Figure 4.
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Table 5: Mean Difference between M2 and M4 for YE Participants after 6 Months
CV Outcome Variable

Younger Elderly
Mean
95% Confidence Interval
Difference
(lower bound, upper
bound)

Ambulatory BP
24-Hr Systolic BP
.31
24-Hr Diastolic BP
1.66
24-Hr peak systolic BP
3.19
24-Hr peak diastolic BP
-.32
24-Hr MAP
-.02
24-Hr HR
2.04
Day Systolic BP
-.07
Day Diastolic BP
-.10
Day peak systolic BP
2.95
Day peak diastolic BP
.04
Day MAP
1.52
Day HR
2.03
Night systolic BP
.21
Night diastolic BP
.69
Night peak systolic BP
-.83
Night peak diastolic BP
.72
Night MAP
.93
Night HR
-.87
Clinical Resting BP
SBP
8.00
DBP
3.79
Arterial Stiffness and Blood Flow Velocity
Carotid IMT
-.04
Carotid AC
.13
Psv
-4.49
Pdv
-2.17
Pedv
-2.29
Pavg
-3.19
CV Fitness
VO2max
-.27

P-Value

-3.85
-4.77
-3.30
-6.56
-2.85
-1.52
-4.58
-8.26
-3.35
-6.33
-1.46
-1.57
-5.15
-3.51
-9.63
-7.61
-3.30
-4.27

4.47
1.45
9.69
5.92
2.81
5.60
4.44
8.06
9.25
6.42
4.51
5.62
5.58
4.89
7.97
9.06
5.16
2.53

.88
.29
.32
.92
.99
.25
.98
.98
.35
.99
.31
.26
.94
.74
.85
.86
.66
.60

-1.28
-1.12

17.28
8.69

.09*
.13

-.09
-.02
-10.93
-4.42
-4.56
-6.63

.02
.28
1.95
.08
-.01
.24

.18
.09*
.17
.058
.05**
.06*

-3.02

2.49

.85

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05)
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Table 6: Mean Difference between M2 and M4 for OE Participants after 6 Months
CV Outcome Variable

Older Elderly
Mean
Difference

Ambulatory BP
24-Hr Systolic BP
-.41
24-Hr Diastolic BP
-.54
24-Hr peak systolic BP
-5.60
24-Hr peak diastolic BP
-3.12
24-Hr MAP
-.47
24-Hr HR
-4.86
Day Systolic BP
.72
Day Diastolic BP
-3.20
Day peak systolic BP
-2.79
Day peak diastolic BP
-1.44
Day MAP
-1.76
Day HR
-4.84
Night systolic BP
-3.30
Night diastolic BP
.70
Night peak systolic BP
-11.24
Night peak diastolic BP
-.88
Night MAP
2.87
Night HR
-2.37
Clinical Resting BP
SBP
6.86
DBP
2.87
Arterial Stiffness and Blood Flow Velocity
Carotid IMT
-.04
Carotid AC
-.04
Psv
-2.40
Pdv
-.41
Pedv
-.28
Pavg
-.60
CV Fitness
VO2max
.97

95% Confidence Interval
(lower bound, upper
bound)

P-Value

-6.71
-3.93
-13.29
-10.01
-4.15
-9.26
-4.55
-11.52
-10.06
-7.59
-6.58
-9.24
-11.53
-3.67
-21.13
-7.26
-2.68
-7.40

5.89
2.84
2.08
3.78
3.20
-.47
5.99
5.12
4.49
4.70
3.06
-.44
4.93
5.08
-1.34
5.50
8.42
2.66

.90
.75
.15
.36
.79
.03**
.78
.44
.44
.63
.46
.03**
.42
.74
.03**
.78
.30
.34

-3.16
-2.89

16.88
8.64

.17
.32

-.13
-.20
-10.15
-2.41
-1.87
-4.22

.05
.12
5.34
1.59
1.32
3.02

.40
.63
.53
.68
.72
.74

-2.38

4.32

.56

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. **significant (p≤.05)
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Figure 3 – YE Significant Outcomes in End-Diastolic Blood Flow Velocity between
Groups. Effects of 6 months of M2 and M4 training on: (a) Pedv, end-diastolic velocity. Point estimates and 95%CI
(confidence interval; lower and upper) bars presented; **significant (p≤.05).
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Figure 4 – OE Significant Outcomes in Ambulatory BP between Groups. Effects of 6
months of M2 and M4 training on: (a) 24-Hr HR, 24-hour hear rate; (b) Day HR, daytime heart rate; (c) Night Sbppk,
nighttime peak systolic blood pressure. Point estimates and 95%CI (confidence intervals; lower and upper) bars
presented; **significant (p≤.05)
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4.4 Results by Sex
Additional analyses were completed based on sex and group to see whether one sex
improved over the other. Both males and females differed on which CV variables
changed significantly.
Males only significantly changed in nighttime HR. The M4 group increased in night HR
compared to the M2 group which decreased. Mean difference between groups was -7.36
(95%CI: -13.05, -1.66; p= .01), see Table 7 and Figure 5.
Conversely, females significantly changed in nighttime peak SBP clinical resting DBP
and end-diastolic velocity. Nighttime peak SBP increased in the M4 group compared to
the M2 group which decreased. Female nighttime peak SBP had a mean group difference
of -7.34 (95%CI: -14.36, -.32). Clinical resting DBP had a greater decrease in the M4
group compared to the M2 group with a between groups mean change of 4.20 (95%CI:
.09, 8.31; p=.05). End-Diastolic velocity within females increased in the M4 group
compared to the M2 group which decreased. Mean difference for females between groups
was -1.65 (95%CI: -3.31, .01; p=.05), see Table 8 and Figure 6.
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Table 7: Mean Difference between M2 and M4 for Males Only Participants
between groups after 6 Months
CV Outcome Variables

Ambulatory BP
24-Hr Systolic BP
24-Hr Diastolic BP
24-Hr peak systolic BP
24-Hr peak diastolic BP
24-Hr MAP
24-Hr HR
Day Systolic BP
Day Diastolic BP
Day peak systolic BP
Day peak diastolic BP
Day MAP
Day HR
Night systolic BP
Night diastolic BP
Night peak systolic BP
Night peak diastolic BP

Mean
Difference

Males
95% Confidence Interval
(lower bound, upper bound)

P-Value

-2.79
-2.31
-1.94
-3.93
-2.52
-5.08
-1.32
-6.00
-2.70
-4.70
-2.90
-5.06
-5.78
-1.66
-4.56
-1.97

-12.54
-7.41
-12.74
-13.43
-7.57
-10.79
-8.59
-16.34
-12.97
-13.46
-9.51
-10.78
-16.85
-9.13
-19.57
-12.21

6.95
2.79
8.86
5.58
2.52
.63
5.95
4.32
7.58
4.06
3.72
.65
5.30
5.81
10.46
8.27

.55
.35
.71
.40
.31
.08*
.71
.24
.59
.27
.37
.08*
.29
.65
.53
.69

-7.75
-13.05

5.40
-1.66

.71
.01**

-4.09
-5.86

26.74
9.74

.14
.61

-.13
-.10
-11.52
-4.04
-3.10
-6.53

.07
.36
8.90
2.04
2.42
3.99

.51
.25
.79
.50
.80
.62

-4.01

4.48

.91

Night MAP
-1.17
Night HR
-7.36
Clinical Resting BP
SBP
11.32
DBP
1.93
Arterial Stiffness and Blood Flow Velocity
Carotid IMT
-.03
Carotid AC
.13
Psv
-1.31
Pdv
-1.00
Pedv
-.34
Pavg
-1.27
CV Fitness
VO2max
..23

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05)
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Table 8: Mean Difference between M2 and M4 for Females Only Participants
between groups after 6 Months
CV Outcome Variables

Ambulatory BP
24-Hr Systolic BP
24-Hr Diastolic BP
24-Hr peak systolic BP
24-Hr peak diastolic BP
24-Hr MAP
24-Hr HR
Day Systolic BP
Day Diastolic BP
Day peak systolic BP
Day peak diastolic BP
Day MAP
Day HR
Night systolic BP
Night diastolic BP
Night peak systolic BP
Night peak diastolic BP
Night MAP
Night HR
Clinical Resting BP
SBP
DBP
Arterial Stiffness
Carotid IMT
Carotid AC
Psv
Pdv
Pedv
Pavg
CV Fitness
VO2max

Females
Mean
Difference

95% CI

P-Value

.55
1.15
-1.14
-1.35
.04
.59
-.05
1.17
.94
.51
.60
.44
-.16
1.50

-3.02
-1.39
-6.99
-6.43
-2.35
-2.43
-4.01
-5.85
-4.48
-4.38
-2.05
-2.66
-5.09
-1.52

4.12
3.70
4.72
3.73
2.43
3.60
3.92
8.19
6.37
5.39
3.24
3.55
4.76
4.53

.76
.37
.70
.59
.98
.70
.98
.74
.73
.84
.65
.78
.95
.32

-7.34
.94
2.47
.78

-14.36
-4.90
-1.38
-2.30

-.32
6.77
6.32
3.85

.04**
.75
.20
.61

3.99
4.20

-3.17
.09

11.15
8.31

.27
.05**

-.03
.05
-3.70
-1.42
-1.65
-2.18

-.10
-.05
-9.11
-3.16
-3.31
-4.92

.04
.15
1.71
.32
.01
.56

.40
.32
.18
.11
.05**
.12

.48

-1.81

2.78

.67

Abbreviations: Estimate of ∆, estimate of change; BP, blood pressure; Hr, hour; CV, Cardiovascular 24HR MAP, 24-hour mean arterial pressure; 24-Hr HR, 24-hour heart rate; Day MAP, daytime mean arterial
pressure; Day HR, daytime heart rate; Night MAP, nighttime mean arterial pressure; Night HR, nighttime
heart rate; Carotid IMT, carotid intima-media thickness; Carotid AC, carotid arterial compliance; Psv, peak
systolic velocity; Pdv, peak diastolic velocity; Pedv, end-diastolic velocity; Pavg, average velocity; VO2max,
maximal oxygen uptake. aParticipants included in N, completed baseline and 6-month data with outliers
removed. bValues are mean ± SD. cAll ambulatory measures obtained from participants with 50%
successful readings. dClinical resting BP used the average of 2nd and 3rd readings. eM2 group used as
reference. *clinical significance (p-value between .06-.09); **significant (p≤.05)
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Figure 5 – Males Significant Outcomes in Ambulatory BP between Groups.

Effects of
6 months of M2 and M4 training on: (a) Night HR, nighttime heart rate; (b) 24-Hr HR, 24-hour heart rate; (c) Day HR,
daytime heart rate. Point estimates and 95%CI (confidence interval; lower and upper) bars presented; **significant
(p≤.05)
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Figure 6 – Females Significant CV Outcomes between Groups. Effects of 6 months of M2
and M4 training on: (a) Night Sbppk, nighttime peak systolic blood pressure; (b) Clinical resting DBP, clinical resting
diastolic blood pressure average readings of 2 and 3; (c) Pedv, end-diastolic velocity. Point estimates and 95%CI
(confidence interval; lower and upper) bars presented; **significant (p≤.05)
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Correlation Analyses
Correlation analyses were conducted at baseline and at 6 months to determine whether
the intervention was strengthened or diminished between two variables that were
correlated.
Bivariate correlation analyses were conducted between 24-hour ambulatory BP variables
and AC at both baseline and at 6-months. Analyses revealed no strong positive or
negative relationships at baseline, except for a positive weak relationship between AC
and 24-hour SBP (r=.22; p=.05), and a negative weak relationship between AC and 24hour HR (r=-.25; p=.02). At 6-months the relationship between AC and 24-hour HR
changed to a strong negative relationship (r= -.05; p≤.01). The remaining variables were
all negligible or weak relationships.
Further correlation analyses were performed between AC, age and BMI. Analyses
revealed at baseline, a weak negative correlation between age and AC at baseline (r=-.02;
p=.83), after 6-months the relationship was weaker (r=-.12; p=.31). AC and BMI were
negligible, however at 6-months, a weak positive relationship was observed (r=.24;
p=.04). See Appendix C for correlation analyses.
Adverse Events
Eight participants suffered an adverse event during the 6-month intervention period. Of
the eight, half of the participants endured an adverse event during the exercise class. The
first participant did not suffer any injuries, but found their HR was too high during the
exercise, and felt a pounding sensation in their chest. The participant walked for 15 mins
to cool down, and rejoined the class once they felt better. The second participant felt
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lightheaded after the strength exercise component. The participant sat down and rested
until they felt better. The third participant felt a sudden pain on the lateral side above
their knee. Exercises were modified to accommodate the knee pain. The last participant
fainted, lost their balance and hit their elbow on the wall during stretching at the end of
the class. Participant got back up and felt fine afterwards. Similarly, another participant
suffered blurred vision and dizziness; however they felt this way prior to exercise class.
Another participant suffered from chronic back pain and it worsened; uncertain of
whether it was exercise class related or not. One participant did not suffer any injuries
during the exercise class, but had personal medical issues which required placement of 3
stents. The participant rejoined the class once recovered. The final participant had a
pinched nerve with leg and back soreness. Pain was amplified during exercise class.
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Chapter 7: Summary and Conclusion
Collective evidence has proposed the aging brain as acquiescent to neuronal and
cognitive plasticity104. Older adults are primarily affected by the decline in cognitive
domains including memory, language and executive function which are all associated
with dementia and therefore require critical attention to the prevention and maintenance
of brain function105,106.
Contributing factors to vascular health such as diet and physical inactivity play a role in
the effects of vascular however; blood pressure and arterial health are the single most
detectable risk factor for dementia excluding age, and the only treatable risk factor to
date26. Although studies have successfully looked at the use of aerobic exercise to prevent
and reduce high blood pressure and arterial stiffness in order to promote brain health in
older adults, the underlying mechanisms are still unclear107.
The current study is the first prospective, 6-month, randomized controlled trial in a
community-dwelling older adult population with subjective memory complaints, which
examines the effects of a multiple modality mind-motor (M4) exercise program on 24hour ambulatory and clinical resting BP, compared to a multiple modality (M2) exercise
program alone. This investigation is notable, as examining the influence of M4 on BP and
other related CV outcomes within this population is important. Furthering our knowledge
of potential ways to mediate and support BP reductions and its advancement may
improve cognitive function and overall risk of CVD within the older adult population.
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Effects of M2 and M4 on ambulatory BP and clinical resting SBP and DBP
For the ambulatory BP outcomes, there were no differences between groups except for
nighttime peak SBP where a significant change was found, with the M2 group decreasing
in peak nighttime SBP compared to the M4 group. The decrease in peak nighttime SBP
can aid in the effect of nocturnal dipping, by which nighttime BP should be 10-15%
lower than daytime BP108. The absence of nocturnal dipping and heightened surge of BP
during the daytime can lead to specific organ damage and augmented CVD risk,
including CVD morbidity and mortality109-112.
On the contrary, the M4 group decreased considerably more compared to the M2 group
in clinical resting SBP. This also coincides with the findings of Corneilissen et al., who
assessed office blood pressure after 10 weeks of either lower or higher intensity training
in adults (age averaged 59 years). Both types of training reduced office BP, however the
higher intensity training reduced SBP even further than the lower intensity training
group112.
By age and group, within the YE between groups, no significant changes were found in
any BP measures. Within sex and between groups, both M2 and M4 females decreased in
clinical resting DBP however the M4 females declined much further.
Conversely, within the OE between groups, 24-hour HR decreased in the M2-OE group
compared to the M4-OE group which had an increase in 24-hour HR. Furthermore, these
findings in 24-hour HR were replicated in daytime HR and nighttime peak SBP. The
Framingham Heart Study (longitudinal cohort study) followed subjects for 30 years and
discovered a continuous increase in SBP between the ages of 30 and 84 years or more.
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However, DBP has a more variable configuration with age, whereby DBP increases until
the age of 50, and slowly decreases from 60 years onwards, resulting in a steep incline in
pulse pressure with aging11. Vasan et al., disturbingly re-counted from the Framingham
Heart Study that 90% of participants, men and women in their mid to late-life were
probable to develop hypertension onwards throughout the rest of their life113. Therefore,
growing evidence has shown the importance of controlling for nighttime BP can greatly
affect the risk of CVD and aging.
When stratified by sex, within the males in the M2 group, a significant decrease in
nighttime HR in comparison to the M4 males whose nighttime HR increased.
Alternatively, females in the M2 group significantly decreased in nighttime peak SBP
compared to the M4 females who increased in nighttime peak SBP. Sierra et al., found
after monitoring 24-hour ambulatory blood pressure, those with a non-dipping profile
were older and often obese women who suffered long-term hypertension, previous
diagnosis of dyslipidemia, Type 2 Diabetes or CVD114. However, within the current
study, nocturnal dipping was not accounted for and should be observed in future studies
as it plays a vital role as we age and between sex.
In general, M2 and M4 groups both improved in certain variables of ambulatory and
clinical resting BP, which help decrease the risk of CVD. Furthermore, Beason-Held et
al., found an association between hypertension and dementia occurrence, whereby studies
have found hypertension with operating brain measures linked to cerebral blood flow115.
Positron emission tomography (PET) data collected on participants with hypertension
(140/90 mm hg) identified with a decline in regional cerebral blood flow over time in
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several cortical regions, including the prefrontal cortex and anterior cingulate cortex
compared to participants without hypertension. This suggests brain areas responsible for
attention and executive function are susceptible to the influences of vascular risk factors
such as hypertension3. However limitations do exist as the study did not assess other
vascular function i.e. cardiac output, endothelial functions or atherosclerotic load which
could suggest participants with hypertension may not be the sole cause for reducing
regional cerebral blood flow, but other vascular risk factors that participants may suffer
from could also contribute to the reduction in regional cerebral blood flow3.
Furthermore, cross-sectional longitudinal studies have shown a positive correlation
between hypertension and cognitive decline, whereby subjects who suffered from
hypertension performed much worse on mental status examinations4. Elevated systolic
pressures in untreated hypertensive, cognitively normal subjects (mean age, 61.3 years)
reduced grey matter volumes in different areas of the brain116, and mid-life hypertension
was associated with a decline in hippocampal volume after a 30 year follow-up7,
suggesting hypertension can alter the brain structurally leading to abnormalities in
cognitive function117. Therefore, control for blood pressure subsequently affects not only
CVD risk, but structural and functional brain alterations. However duration of treatment
or chronicity of hypertension was not documented, although majority (84%) of
participants were diagnosed with hypertension for over 10 years, consequently detecting
the effect of long-term hypertension on the central nervous system117. Better control of
blood pressure is indicative of the prevention of dementia in late-life.
Although the current study lacked in number of significant changes in BP, more than half
of our participants were diagnosed as hypertensive of which only 31 individuals were
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taking medication. However, their regional cerebral blood flow was not monitored;
perhaps not many changes in BP occurred because structurally their brain had already
been altered, to the extent that treating blood pressure could not reverse the effects.
Therefore, monitoring regional cerebral blood flow in conjunction with BP and its
possible predictive pathway for dementia could elucidate the appropriate method of
prevention of hypertension and other vascular risk factors117.
Additionally, the current investigation was part of a larger-scale study of which
biological determinants of exercise and cognition are to be explored in further detail.
Though it is known CV health does play a role in cognition and exercise can improve CV
health, the influence of CV health on cognition still requires further research.
Effects of M2 and M4 on carotid arterial stiffness, blood flow velocity and CV
fitness
Neither M2 nor M4 had any significant influence on carotid arterial stiffness (AC and
IMT), blood flow velocity or CV fitness. It is possible that increasing IMT with age may
be due to external exposures to risk factors that were not disclosed or known118.
When further stratified by age, YE improved only in blood flow velocity, of which only
Pedv had a significant change between M2 and M4. M4-YE had increased in Pedv
compared to the M2-YE which decreased. Within the OE between groups, no significant
changes were found in carotid arterial stiffness, blood flow velocity or CV fitness. It was
determined by Ahzim et al., that an age-associated decline in blood flow velocities in the
common carotid artery was altered and improved in those who were healthy, middle-aged
or older who performed habitual aerobic exercise 119. However with reference to this
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study, improved blood flow velocities of the common carotid artery was only found in
the M4 group and in the YE group when further stratified, regardless of health or habitual
exercise.
The only significance found by sex was a significant change of Pedv in females. The M4
females had an increase in Pedv whereas the M2 females decreased in Pedv. This
contradicts the observations by Denarie et al., who did not observe changes in pulse wave
velocity but rather found a trend in lowering IMT in women than in men on both sides of
the carotid artery and at different ages; however they found middle-aged adults on the left
side to have a statistically significant decrease in IMT118. Though, the fact there was no
significant changes in our study population could attribute to age-related arterial
hypertrophy in both sexes118. Yet, sex differences in carotid artery dimensions still
remain unclear.
CV fitness was not significantly altered when observed by group, within age-between
groups or within sex-between groups. This was contradictive to studies including Linde
et al., and Fabre et al., who found improvement in VO2max for almost all of their
intervention variables except for one (mental training + aerobic training) in the study by
Fabre et al. Furthermore, they found an increase in their control groups as well22,69.
Correlation Analyses
Correlations between AC and blood pressure remained weak or negligible except for AC
and 24-hour HR which had a strong negative relationship. However, systolic and diastolic
BP were both highly correlated with their peak BP counterparts for all three time frames
(24 hours, daytime and nighttime) at baseline. After 6 months, relationships remained
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strongly correlated to one another. Analyses regarding AC, age and BMI revealed only
weak correlations both at baseline and at 6-months.
These correlations are were not very comparable to the findings by Iannuzzi et al., by
which correlations among age, systolic blood pressure, and BMI were positively
correlated with external and internal common carotid diameters120.
7.1 Study Limitations
The results of the current study are novel and meaningful, however, limitations do exist.
A limitation of the present study is the data used for ambulatory blood pressure measures.
Some participants only had the minimum amount of readings (20/40 readings) with very
few nighttime readings, which could skew the data. Therefore, these results should be
interpreted with caution. Although a diary was given to the participant to record any
events that may elevate their blood pressure, some participants may have changed their
regular routine as a consequence of wearing the monitor for the 24-hours, therefore
readings could be inaccurate. Another factor that may or may not have been recorded that
also play a role in the effect of BP, which were not accounted for included anxiety, a
consequence of the sympathetic nervous system (SNS) influenced by the emotional
state121. A chronic level of anxiety in a person has been identified to be an association
between environmental stress and cardiovascular responses that may arbitrate the
formation of or contribute to chronic hypertension122.
A limitation was also found in the ultrasound measurement of the common carotid
arterial wall by which discrepancies in the measurement could have occurred. On
occasion, arterial wall imaging can be unclear on the ultrasound monitor, or the
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endothelial layer may not be clearly defined, resulting in subjective measurements, which
may not be as accurate. Although inter-intra reliability was conducted, it was not reported
due to greater than average discrepancies in arterial diameters within a participant. The
discrepancies lie in the movement of the cursor, where a mere single movement of the
cursor can change the measurement by one- tenths of a millimeter consequently
increasing the variability in measurements.
Moreover, ultrasound images were not recorded to allow revisions of the artery and
ensure accurate measurements were taken. Furthermore, not measuring both left and right
sides of the carotid artery can also impact results, as they tend to differ over age118.
Although Denarie et al., also found unknown differences between the right and left, the
anatomical position of each artery is different. The left common carotid artery is directly
branched on the aorta whereas the right common carotid results from the division of the
brachiocephalic trunk. Therefore, it is possible to have differences in arterial growth
between both arteries118.
Another limitation was that several participants were under treatment for various
medications, which could also influence the results. Although BP, cardiovascular and
other related medications were noted, they were only monitored at the beginning and end
of the intervention. Some participants in the study had untreated high BP, cholesterol, and
diabetes, which could also impact the results of the current investigation. Likewise,
interactions with other medications could have also interfered with the results. In
addition, reporting bias of medication, medical history and cognitive complaint could
also be a factor. Some individuals may have said ‘yes’ to having a cognitive complaint
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but did not actually have any concerns with their memory. Jessen et al., relayed his
concern of how to conceptualize having a subjective cognitive complaint and determined
a more accurate way of identifying the at risk population of cognitive decline123.
Although we asked our participants if they had a subjective cognitive complaint, we did
not ask them whether or not they were concerned which would determine whether they
were at risk for cognitive decline in combination with observing AD biomarkers (i.e.
brain anatomy including glucose metabolism124, amyloid deposition125; cerebral spinal
fluid markers including Aß42126) that could help identify the preclinical stage of
cognitive decline, according to Jessen and colleagues.
Additionally, the current study may be under powered as we only had a total of 89
participants of which less than half were compliant (80% or more attendance) with the
exercise class. Therefore, the lack of changes between group, age and group, and sex and
group could be attributed to the undersized population which affected the statistical
power of the study. While stratifying by age and by sex is important, it may not be the
best way to accurately observe results. Shimzu et al., suggested stratifying by functional
mobility may be more important than looking between age and sex because an
individual’s mobility would have an impact on how strenuous an exercise they can
handle59. Furthermore, some participants may not have reached their target HR each
class, and therefore did not receive the optimal training to better improve CV health. This
could also raise the question whether the prescribed exercises were enough to observe a
change in vascular health.
Lastly, our study population was predominantly Caucasian, which does not necessarily
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reflect the population of older adults at large. Therefore, future studies should consider
more ethnic groups in their population.
7.2 Perspectives
As we age, the prevalence of cognitive impairment increases with age and the incidence
of individuals displaying some form of cognitive impairment prior to meeting any
diagnostic criteria for dementia (i.e., mild cognitive impairment; MCI, or cognitive
impairment not dementia; CIND) is doubled, compared to Alzheimer’s disease and
related dementias127. Therefore, it is imperative to look at older adults who have selfreported claims of poorer cognition regardless of having an actual indication of cognitive
impairment to better control the incidence of dementia in later-life128-131.
Furthermore, CVD risk factors such as hypertension and arterial stiffness are also on the
rise as we age, and have been confirmed as a contributing factor towards dementia and its
progression to Alzheimer’s Disease64,132. An editorial in the Journal of the American
Medical Association states the most readily modifiable risk factors of dementia are
vascular risk factors. Front-line prevention measures and treatment strategies for CVD
risk factors include lifestyle modifications such as incorporating habitual, moderate to
vigorous aerobic exercise133. Aerobic exercise has been proven to mitigate CVD risk
factors by reducing BP133,134 and arterial stiffness in older adults48.
Previous research has also found aerobic exercise improved CVD risk factors and
cognitive function, specifically executive function in healthy older adults and those with
cognitive impairment20,134-137, demonstrating the association between CVD risk factors
and cognition . Increases in cardiovascular fitness enhanced important regions of the
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brain including the attentional network134; however, the neural mechanisms responsible
for enhancement in cognition due to improved CVD risk factors in aging adults have not
been fully investigated134. Additionally, cognitive training has also been shown to
improve executive function and memory in healthy older adults and in cognitively
impaired older adults21,50.
Due to the observed fixed association between cognition and vascular health20,134-137, the
use of cognitive training to improve vascular health the current study incorporated a
multiple modality and mind-motor training program to see whether both prescriptions
given together would benefit CVD risk factors, in turn improving cognition in older
adults. In addition, elucidating the optimal regimen for preserving CVD risk factors and
cognition.
This study conducted a larger-scale randomized controlled trial of community-dwelling
older adults who have a subjective memory complaint and found some evidence of a
beneficial impact from a multiple modality mind-motor program on CV health. However
future research should look at nocturnal dipping and cerebral blood flow as outcome
measures to understand physiologically, the CV mechanisms within the brain. More
ethnic groups should also be included to better generalize the findings of the intervention
in an older adult population. Furthermore, better control of external factors such as
anxiety and stratifying by physical function levels should be further investigated when
looking at a combined aerobic and cognitive training exercise program on vascular
health.
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Appendix B. Table 1: Description and Scoring Rubric for CBS Games
Task Name
1. Monkey
Ladder
(Visuospatial
working
memory)

Cognitive
Domain
Memory

Literature
Informing Task

Brief Description

Outcome Measure

Sets of numbered squares are
displayed all at the same time at
random locations within an
invisible
5x5 grid.

Maximum level achieved Non-human
primate
(Maximum = 25;
literature 142
Minimum =2)

After a variable interval, the
numbers are removed leaving just
the blank squares visible.
A tone cues the participant to
Reasoning Problems of the form “The
2. Grammatical
respond by clicking on the
square is not encapsulated by
Reasoning
squares in ascending numerical
the circle” are displayed on the
(Verbal Reasoning)
sequence.
screen and the participant must
indicate whether the statement
correctly describes a pair of
objects displayed in the centre
of the screen.

Total score – which
increases or decreases
by 1 after each trial
depending on whether
responses are correct.

Alan Baddeley’s
3minute
grammatical
reasoning test
143

The first trial has
four numbers. The

3. Double Trouble
(Color-Word
Re-mapping)

In order to achieve
maximum points, the
Reasoning A colored word is displayed at
participant must solve as
the top of the screen, for
many problems as possible
example the word RED drawn
within 90 seconds.
in blue ink.
Participants must indicate which
of two colored words at the bottom
of the screen describes the color
that the word at the top of the
screen is drawn in.
The color word mappings may be
congruent, incongruent, or
doubly incongruent, depending
on whether or not the color that a
given word describes matches

the color that it is drawn in.
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maximum level is
Total score
25 and the
To
gain level is 2.
minimum
maximum points,
the participant
must solve as
many problems
as possible
within 90
seconds.
The total score
increases or decreases
by 1 after each trial
depending on whether
they responded
correctly.

More
challenging
variant of the
Stroop test 144

Literature
Task Name Cognitive

Brief Description

Outcome Measure

A 3x3 grid of cells is displayed on
the screen. Each cell contains a
variable number of copies of a
colored shape.

Total correct

Domain
4. Odd One Reasoning
Out
(Deductive
Reasoning)

5. Spatial
Span
Blocks
(Spatial
Span)

6. Rotations Concentration
(Spatial
Rotation)

Task

The features that make up the
objects in each cell (color, shape,
number of copies) are related to
each other according to a set of
rules.

Memory

Informing

The participant must deduce the
rules that relate the object features
and select the one cell whose
contents do not correspond to those
16 squares are displayed in a 4x4
rules.
grid. A sub-set of the squares flash in
a random sequence at a rate of 1 flash
every 900 ms.

To gain maximum points,
the participant must solve
as many problems as
possible within 90
seconds.

Sub-set of
problems
from the
Cattell
Culture Fair
Intelligence
Test 145

If the response is correct, the
total score increases by one
point and the next problem is
more complex. If the response
is incorrect, the total score
decreases by 1 point.
Maximum level achieved
(Maximum = 16;

Corsi Block
Trapping
146

Minimum = 2)

Task

Total score

Spatial
Rotation tasks
are often used
for measuring
the ability to
manipulate
objects

Subsequently, the mouse cursor is
displayed and a tone cues the
participant to repeat the sequence by
clicking on the squares in the same
order in which they flashed.

In this variant, 2 grids of colored
squares are displayed to either
side of the screen with 1 of the
grids rotated by a multiple of
90°.
When rotated, the grids are either
identical or differ by the position of
just 1 square.
In order to gain maximum
points, the participant must
indicate whether the grids are
identical, solving as many
problems as possible within 90
seconds.
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If the response is correct, the
total score increases by the
number of squares in the grid
and subsequent trials have
more squares.
If the response is incorrect the
total score decreases by the
number of squares in the grid
and subsequent trials have
fewer squares. The first grids
contain 4 colored squares each.

spatially in
mind 147

Literature
Task Name Cognitive
Concentration
7. Feature
Domain
Match

Brief Description
Two grids are displayed
on the screen, each
containing a set of abstract
shapes.

Outcome Measure
Total score

If the response is correct, the
total score increases by the
number of shapes in the grid
and the number of shapes in
subsequent trials increases.

In half of the trials the grids
differ by just one shape.

8. Digit

Memory

Span

In order to gain maximum points,
the participant must indicate
whether or not the grid’s contents
are identical, solving as many
problems as possible within 90
seconds.
Participants view a sequence of
digits that appear on the screen
one after another.

If the response is incorrect, the
total score decreases by the
number of shapes in the grid
and subsequent trials have
fewer shapes. The first grids
contain two abstract shapes
Maximum
level achieved
each.
(Maximum level = 25;
Minimum level = 2)

Hampshire

Planning

Numbered beads are positioned
on a tree shaped frame.

Total score

Tree Task
(Spatial
Planning)

Computerised
variant on the
verbal working
memory
component
of
the
WAISR

Subsequently, they repeat the
sequence of numbers by entering
them on the keyboard.
9.

Informing
Classic
Task feature
search tasks
that have
historically
been used to
measure
attentional
processing 148

The participant repositions the
beads so that they are configured
in ascending numerical order
running from left to right and top
to bottom of the tree.

After each trial, the total score
is incremented by adding the
minimum number of moves
required ×2 – the number of
moves actually made, thereby
rewarding efficient planning.

Created by: Gill DP., Gregory M., Petrella R. M4 Grant Applications
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intelligence
149
Based
test on
Tower of
London
Task 150 –
widely used
to
measure
executive
function.

Appendix B. Table 2: Square Stepping Exercise example patterns
Beginner Pattern – focused on walking-like movements and simple steps

i)
2

Start
Walk

4
3

1
ii)
Start
Walk

3
1
2

2
6

5

4
3

1

6

Finish
Walk

5

Intermediate Pattern – incorporates forward, lateral and diagonal movements
5
3
5
3
5
3
5
4
1
4
1
4
1
4
Finish
6
2
6
2
6
2
6
Walk

iii)
Advanced Pattern – a large number of steps per pattern with multiple movement
types
Start
Walk

1
4

3
2

7
6

5
8

1
4

3
2

7
6

5
8

Finish
Walk

Created by: Gill DP., Petrella R. M4 Grant Applications

•

Numbers represent consecutive footsteps

•

As designed, we will run the SSE in a group format, whereby 5-6 participants
will be designated to a specific SSE mat.

•

Participants will progress as a group to the next step pattern after 80% of
participants can perform the pattern smoothly.

•

For any advanced participants, there are mechanisms by which difficulty can be
increased within a current pattern (i.e., increasing step speed; avoiding square
frames, etc.).
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Correlation Analyses
Correlation between AC and baseline 24-hour ambulatory BP
Correlations

Pearson Correlation
x24sbpavg
Sig. (2-tailed)
.0
N
Pearson Correlation
x24dbpavg
Sig. (2-tailed)
.0
N
Pearson Correlation
x24sbppk.
Sig. (2-tailed)
0
N
Pearson Correlation
x24dbppk.
Sig. (2-tailed)
0
N
Pearson Correlation
x24map.0

x24hr.0

ac.0

x24sbpavg.
0

x24dbpavg.
0

1

.635**

.869**

.536**

.844**

.047

.217

.000

.000

.000

.000

.670

.051

85
1

85
.422**

85
.734**

85
.859**

85
.087

82
.076

.000

.000

.000

.429

.495

85
1

85
.444**

85
.740**

85
-.054

82
.163

.000

.000

.622

.145

85
1

85
.666**

85
.193

82
-.017

.000

.076

.881

85
1

85
.053

82
.157

.628

.158

85
1

82
-.253*

85
.635**

x24sbppk. x24dbppk.
0
0

.000

x24map.0

x24hr.0

85
.869**

85
.422**

.000

.000

85
.536**

85
.734**

85
.444**

.000

.000

.000

85
.844**

85
.859**

85
.740**

85
.666**

Sig. (2-tailed)

.000

.000

.000

.000

N
Pearson Correlation

85
.047

85
.087

85
-.054

85
.193

85
.053

Sig. (2-tailed)

.670

.429

.622

.076

.628

N
Pearson Correlation

85
.217

85
.076

85
.163

85
-.017

85
.157

85
-.253*

Sig. (2-tailed)

.051

.495

.145

.881

.158

.022

82

82

82

82

82

82

N

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).

109

ac.0

.022
82
1

85

Correlation between AC and 6-month ambulatory BP
Correlations

Pearson Correlation
x24sbpavg.
Sig. (2-tailed)
1
N
Pearson Correlation
x24dbpavg.
Sig. (2-tailed)
1
N
Pearson Correlation

1

.644**

.821**

.304**

.881**

-.016

.098

.000

.000

.010

.000

.895

.424

71
1

71
.480**

71
.461**

71
.898**

71
.132

69
.220

.000

.000

.000

.273

.070

71
1

71
.358**

71
.697**

71
-.085

69
.201

.002

.000

.481

.097

71
1

71
.389**

71
.030

69
.124

.001

.806

.312

71
1

71
.035

69
.199

.772

.102

71
1

69
-.458**

71
.480**

.000

.000

71
.304**

71
.461**

71
.358**

.010

.000

.002

71
.881**

71
.898**

71
.697**

71
.389**

.000

.000

.000

.001

71
-.016

71
.132

71
-.085

71
.030

71
.035

Sig. (2-tailed)

.895

.273

.481

.806

.772

N
Pearson Correlation

71
.098

71
.220

71
.201

71
.124

71
.199

71
-.458**

Sig. (2-tailed)

.424

.070

.097

.312

.102

.000

69

69

69

69

69

69

N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation

N

**. Correlation is significant at the 0.01 level (2-tailed).

Correlation between baseline AC, Age and BMI
Correlations
bmi.0
Pearson Correlation
bmi.0

Pearson Correlation
Sig. (2-tailed)
N

ac.0

age.0
1

ac.0

-.169

.054

.114

.621

89

89

85

-.169

1

-.024

Sig. (2-tailed)
N

age.0

x24hr.1

71
.821**

x24dbppk.1 Sig. (2-tailed)

ac.1

x24sbppk. x24dbppk. x24map.
1
1
1

.000

N
Pearson Correlation

x24hr.1

x24dbpavg.
1

71
.644**

x24sbppk.1 Sig. (2-tailed)

x24map.1

x24sbpavg.
1

.114

.825

89

89

85

Pearson Correlation

.054

-.024

1

Sig. (2-tailed)

.621

.825

85

85

N

110

85

ac.1

.000
69
1

72

Correlation between 6-month AC, and baseline Age and BMI
Correlations
age.0
Pearson Correlation
age.0

Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
ac.1

1

Sig. (2-tailed)
N

ac.1

-.169

-.122

.114

.307

89

89

72

-.169

1

.243*

Sig. (2-tailed)
N

bmi.0

bmi.0

.114

.040

89

89

72

-.122

.243*

1

.307

.040

72

72

*. Correlation is significant at the 0.05 level (2-tailed).
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